US20120277737A1 - Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy - Google Patents
Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy Download PDFInfo
- Publication number
- US20120277737A1 US20120277737A1 US13/445,034 US201213445034A US2012277737A1 US 20120277737 A1 US20120277737 A1 US 20120277737A1 US 201213445034 A US201213445034 A US 201213445034A US 2012277737 A1 US2012277737 A1 US 2012277737A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- elongate body
- temperature
- ablation
- temperature sensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/08—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
- A61B18/082—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3203—Fluid jet cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1477—Needle-like probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/16—Indifferent or passive electrodes for grounding
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B17/00—Pumps characterised by combination with, or adaptation to, specific driving engines or motors
- F04B17/03—Pumps characterised by combination with, or adaptation to, specific driving engines or motors driven by electric motors
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B41/00—Pumping installations or systems specially adapted for elastic fluids
- F04B41/02—Pumping installations or systems specially adapted for elastic fluids having reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00041—Heating, e.g. defrosting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00744—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00797—Temperature measured by multiple temperature sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00809—Temperature measured thermochromatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
- A61B2018/00821—Temperature measured by a thermocouple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
- A61B2018/046—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1425—Needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/16—Indifferent or passive electrodes for grounding
- A61B2018/162—Indifferent or passive electrodes for grounding located on the probe body
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B19/00—Machines or pumps having pertinent characteristics not provided for in, or of interest apart from, groups F04B1/00 - F04B17/00
- F04B19/20—Other positive-displacement pumps
- F04B19/22—Other positive-displacement pumps of reciprocating-piston type
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/02—Machines, pumps, or pumping installations having flexible working members having plate-like flexible members, e.g. diaphragms
- F04B43/04—Pumps having electric drive
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B49/00—Control, e.g. of pump delivery, or pump pressure of, or safety measures for, machines, pumps, or pumping installations, not otherwise provided for, or of interest apart from, groups F04B1/00 - F04B47/00
- F04B49/06—Control using electricity
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49016—Antenna or wave energy "plumbing" making
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49082—Resistor making
- Y10T29/49085—Thermally variable
Abstract
Devices and methods for monitoring the temperature of tissue at various locations in a treatment volume during fluid enhanced ablation therapy are provided. In one embodiment, an ablation device is provided having an elongate body, at least one ablation element, and at least one temperature sensor. The elongate body includes a proximal and distal end, an inner lumen, and at least one outlet port to allow fluid to be delivered to tissue surrounding the elongate body. The at least one ablation element is configured to heat tissue surrounding the at least one ablation element. The at least one temperature sensor can be positioned a distance away from the at least one ablation element and can be effective to output a measured temperature of tissue spaced a distance apart from the at least one ablation element such that the measured temperature indicates whether tissue is being heating to a therapeutic level.
Description
- This application claims priority to U.S. Provisional Application Ser. No. 61/474,574, filed on Apr. 12, 2011, and entitled “Improvement in Ablation Catheters.” This application is also related to U.S. application Ser. No. 13/445,040 entitled “Methods and Devices for Use of Degassed Fluids with Fluid Enhanced Ablation Devices,” U.S. application Ser. No. 13/445,036 “Methods and Devices for Heating Fluid in Fluid Enhanced Ablation Therapy,” U.S. application Ser. No. 13/445,373 “Methods and Devices for Controlling Ablation Therapy,” and U.S. application Ser. No. 13/445,365 “Devices and Methods for Shaping Therapy in Fluid Enhanced Ablation,” respectively, and filed concurrently with the present application. The disclosures of each of these applications are hereby incorporated by reference in their entirety.
- The present invention relates generally to fluid enhanced ablation, such as the SERF™ ablation technique (Saline Enhanced Radio Frequency™ ablation). More particularly, this invention relates to devices and methods for monitoring temperature during fluid enhanced ablation at various locations relative to an ablation element.
- The use of thermal energy to destroy bodily tissue can be applied to a variety of therapeutic procedures, including the destruction of tumors. Thermal energy can be imparted to the tissue using various forms of energy, such as radio frequency electrical energy, microwave or light wave electromagnetic energy, or ultrasonic vibrational energy. Radio frequency (RF) ablation, for example, is effected by placing one or more electrodes against or into tissue to be treated and passing high frequency electrical current into the tissue. The current can flow between closely spaced emitting electrodes or between an emitting electrode and a larger, common electrode located remotely from the tissue to be heated.
- One disadvantage with these techniques is that maximum heating often occurs at or near the interface between the therapeutic tool and the tissue. In RF ablation, for example, the maximum heating can occur in the tissue immediately adjacent to the emitting electrode. This can reduce the conductivity of the tissue, and in some cases, can cause water within the tissue to boil and become water vapor. As this process continues, the impedance of the tissue can increase and prevent current from entering into the surrounding tissue. Thus, conventional RF instruments are limited in the volume of tissue that can be treated.
- Fluid enhanced ablation therapy, such as the SERF™ ablation technique (Saline Enhanced Radio Frequency™ ablation), can treat a greater volume of tissue than conventional RF ablation. The SERF ablation technique is described in U.S. Pat. No. 6,328,735, which is hereby incorporated by reference in its entirety. Using the SERF ablation technique, saline is passed through the needle and heated, and the heated fluid is delivered to the tissue immediately surrounding the needle. The saline helps distribute the heat developed adjacent to the needle and thereby allows a greater volume of tissue to be treated with a therapeutic dose of ablative energy. The therapy is usually completed once a target volume of tissue reaches a desired therapeutic temperature, or otherwise receives a therapeutic dose of energy.
- However, it can be challenging to determine with precision when a particular targeted volume of tissue has received the desired therapeutic dose of energy. For example, Magnetic Resonance Imaging (MRI) can be used during ablation therapy to monitor the extent of the developing treatment zone, but MRI is often prohibitively costly for this type of procedure. Ultrasonic imaging can also be used, but does not reliably or accurately depict the volume of the treatment zone.
- Furthermore, while fluid enhanced ablation therapy generally creates treatment zones in tissue surrounding an ablation device that are spherical in shape, anatomical features and differences in tissue types can result in non-uniform propagation of the treatment zone. Accordingly, in some cases it can be desirable to correct for a developing non-uniform treatment zone that results from anatomical features in the targeted volume of tissue (e.g., a nearby blood vessel that is moving heat away from a treatment zone). Moreover, in some situations it can be desirable to create a treatment zone having a non-standard shape. Corrective or other shaping of the developing therapy treatment zone cannot be accomplished, however, without accurate measurements of the temperature in tissue surrounding the ablation device.
- Accordingly, there remains a need for devices and techniques for more accurately and reliably monitoring the temperature of tissue during fluid enhanced ablation therapy.
- The present invention generally provides devices and methods for monitoring the temperature of tissue at various locations within a treatment volume during fluid enhanced ablation. In one aspect, an ablation device is provided including an elongate body having a proximal end, a distal end, an inner lumen extending therethrough, and at least one outlet port configured to allow fluid flowing through the inner lumen to be delivered to tissue surrounding the elongate body when the elongate body is introduced into a tissue mass. The device further includes at least one ablation element disposed along the elongate body adjacent to the at least one outlet port, the at least one ablation element being configured to heat tissue within a treatment zone surrounding the at least one ablation element when the distal end of the elongate body is introduced into a tissue mass. The device can also include at least one temperature sensor coupled to the elongate member and positioned a distance apart from the at least one ablation element. The at least one temperature sensor is effective to output a measured temperature of tissue spaced a distance apart from tissue adjacent to the at least one ablation element such that the measured temperature indicates whether tissue is being heating to a therapeutic level.
- The ablation device of the present invention can have a number of additional features and modifications. For example, the at least one temperature sensor can be positioned on the elongate body at a location proximal to the at least one ablation element. Alternatively, the at least one temperature sensor can be positioned on the elongate body at a location distal to the at least one ablation element. In other embodiments, the at least one temperature sensor can include a plurality of temperature sensors spaced apart from one another and positioned axially along the elongate body. In still other embodiments, the at least one temperature sensor can include a first temperature sensor positioned distal of the at least one ablation element, and a second temperature sensor positioned proximal of the at least one ablation element.
- In some embodiments, the elongate body can include a plurality of tines configured to extend outward from the elongate body, and the at least one temperature sensor can include a plurality of temperature sensors. Each of the plurality of tines can have one of the plurality of temperature sensors located at a distal tip thereof. In other embodiments, each of the plurality of tines can have two or more of the plurality of temperature sensors disposed along a length thereof. In still other embodiments, the at least one temperature sensor can be located on an outer surface of the elongate body. Alternatively, the at least one temperature sensor can be located in the inner lumen and can contact an outer wall of the elongate body. In still other embodiments, the at least one temperature sensor can be located in a recess formed in the elongate body. In some embodiments, the at least one temperature sensor can be thermally isolated from the elongate body. In other embodiments, a position of the at least one temperature sensor can be adjustable along a length of the elongate member. In certain embodiments, the at least one temperature sensor can be a thermocouple. In other embodiments, the temperature sensor can be a wireless temperature sensor.
- In another aspect, a system for delivering saline enhanced ablation is provided that includes an elongate body having proximal and distal ends, an inner lumen extending through the elongate body, at least one outlet port formed in the elongate body, and at least one ablation element positioned along the length of a distal portion of the elongate body. The system can also include a fluid source in communication with the inner lumen of the elongate body and configured to deliver fluid through the inner lumen such that fluid can flow through the at least one outlet port and be delivered to tissue surrounding the at least one ablation element. The system can further include at least one temperature sensor coupled to the elongate body and positioned a distance apart from the at least one ablation element such that the at least one temperature sensor is effective to measure a temperature of tissue spaced a distance apart from tissue adjacent to the at least one ablation element. The system can also include a control unit configured to obtain a temperature of the ablation element and a temperature measured by the at least one temperature sensor, and a temperature measured by the at least one temperature sensor can indicate whether tissue within a treatment zone is being heated to a therapeutic level.
- In some embodiments, the control unit can be configured to adjust at least one of a flow rate of the fluid flowing through the elongate body, an ablative energy level of the ablation element, and a temperature of the fluid being delivered in response to a temperature measured by the at least one temperature sensor.
- In another aspect, a method for ablating tissue is provided that includes inserting a needle body into a tissue mass, the needle body having an ablation element disposed thereon and at least one temperature sensor coupled thereto and effective to measure a temperature of the tissue mass at a distance away from tissue immediately adjacent to the ablation element. The method can include simultaneously delivering fluid through the needle body and into the tissue mass surrounding the needle body, and delivering therapeutic energy to the ablation element on the needle body to heat the tissue mass surrounding the needle body. The at least one temperature sensor can measure a temperature of the tissue mass at a distance away from the tissue immediately adjacent to the ablation element.
- In some embodiments, the method can include adjusting at least one of a flow rate of the fluid flowing through the needle body, an ablative energy level of the ablation element, and a temperature of the fluid being delivered. In other embodiments, the tissue located a distance away from the tissue immediately adjacent to the ablation source can be at the periphery of a desired treatment zone. In another embodiment, the method can include ceasing delivery of therapeutic energy once the temperature measured by the at least one temperature sensor reaches a predetermined level. In still other embodiments, the method can include determining a therapeutic dose delivered to the tissue mass based on measurements from the at least one temperature sensor, and ceasing delivery of therapeutic energy once the thermal dose delivered to the tissue mass reaches a predetermined level.
- In another aspect, a method for therapeutically treating tissue is provided that includes inserting a needle body into a tissue mass, the needle body having one or more outlet ports formed therein. The method further includes delivering fluid heated to a therapeutic temperature into the tissue mass through the one or more outlet ports to heat the tissue mass surrounding the needle body, and measuring a temperature of the tissue mass at a distance away from the tissue immediately adjacent to the one or more outlet ports. In some embodiments, measuring a temperature of the tissue mass can include detecting the temperature using a temperature sensor disposed along the length of the needle body.
- The aspects and embodiments of the invention described above will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
-
FIG. 1 is a diagram of one embodiment of a fluid enhanced ablation system; -
FIG. 2 is a perspective view of one embodiment of a medical device having an elongate body for use in fluid enhanced ablation; -
FIG. 3 is a graphical representation of simulated heating profiles for various forms of ablation; -
FIG. 4 is a side view of a distal portion of an elongate body showing the expansion of a treatment zone over time; -
FIG. 5 is a graphical representation of variation in heating profiles during fluid enhanced ablation; -
FIG. 6 is a side view of a distal portion of an elongate body having a temperature sensor located remotely from an ablation element; -
FIG. 7 is a side view of a distal portion of an elongate body having a plurality of temperature sensors located remotely from an ablation element; -
FIG. 8 is an exploded perspective view of one embodiment of an elongate body having a thermocouple embedded in a sidewall thereof; -
FIG. 9A is a cross-sectional view of one embodiment of an insulating tube configured to insulate a thermocouple from fluid flowing therethrough; -
FIG. 9B is a cross-sectional view of one embodiment of an elongate body having an insulating tube disposed therein; -
FIG. 10 is a perspective view of one embodiment of an elongate body having thermocouples disposed at the ends of elastic tines extending from the elongate body; -
FIG. 11 is a perspective view of an alternative embodiment of an elongate body having thermocouples disposed at the ends of elastic tines extending from the elongate body; -
FIG. 12 is a side view of one embodiment of an elongate body having a plurality of ablation elements and temperature sensors; -
FIG. 13 is a graphical representation of dynamic heating profiles that can be achieved using the elongate body ofFIG. 12 ; and -
FIG. 14 is a perspective, semi-transparent view of the elongate body ofFIG. 12 showing the elongate body divided into portions that can each independently receive fluid at a given temperature. - Certain exemplary embodiments will now be described to provide an overall understanding of the principles of the devices and methods disclosed herein. One or more examples of these embodiments are illustrated in the accompanying drawings. Those skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments and that the scope of the present invention is defined solely by the claims. The features illustrated or described in connection with one exemplary embodiment may be combined with the features of other embodiments. Such modifications and variations are intended to be included within the scope of the present invention.
- The terms “a” and “an” can be used interchangeably, and are equivalent to the phrase “one or more” as utilized in the present application. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. The terms “about” and “approximately” used for any numerical values or ranges indicate a suitable dimensional tolerance that allows the composition, part, or collection of elements to function for its intended purpose as described herein. These terms generally indicate a ±10% variation about a central value. Components described herein as being coupled may be directly coupled, or they may be indirectly coupled via one or more intermediate components. The recitation of any ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited. Further, to the extent that linear or circular dimensions are used in the description of the disclosed devices, systems, and methods, such dimensions are not intended to limit the types of shapes that can be used in conjunction with such devices, systems, and methods. A person skilled in the art will recognize that an equivalent to such linear and circular dimensions can easily be determined for any geometric shape.
- All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”), provided herein is intended merely to better illuminate the invention and does not impose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention. Further, to the extent the term “saline” is used in conjunction with any embodiment herein, such embodiment is not limited to use of “saline” as opposed to another fluid unless explicitly indicated. Other fluids can typically be used in a similar manner.
- Fluid Enhanced Ablation Systems
- The present invention is generally directed to devices and methods for remote temperature monitoring in fluid enhanced ablation devices. Fluid enhanced ablation, as mentioned above, is defined by passing a fluid into tissue while delivering therapeutic energy from an ablation element. The delivery of therapeutic energy into tissue can cause hyperthermia in the tissue, ultimately resulting in necrosis. This temperature-induced selective destruction of tissue can be utilized to treat a variety of conditions including tumors, fibroids, cardiac dysrhythmias (e.g., ventricular tachycardia, etc.), and others.
- Fluid enhanced ablation, such as the SERF™ ablation technique (Saline Enhanced Radio Frequency™ ablation) described in U.S. Pat. No. 6,328,735 and incorporated by reference above, delivers fluid heated to a therapeutic temperature into tissue along with ablative energy. Delivering heated fluid enhances the ablation treatment because the fluid flow through the extracellular space of the treatment tissue can increase the heat transfer through the tissue by more than a factor of twenty. The flowing heated fluid convects thermal energy from the ablation energy source further into the target tissue. In addition, the fact that the fluid is heated to a therapeutic temperature increases the amount of energy that can be imparted into the tissue. Finally, the fluid can also serve to constantly hydrate the tissue and prevent any charring and associated impedance rise.
-
FIG. 1 illustrates a diagram of one exemplaryfluid ablation system 100. The system includes anelongate body 102 configured for insertion into a target volume of tissue. The elongate body can have a variety of shapes and sizes according to the geometry of the target tissue. Further, the particular size of the elongate body can depend on a variety of factors including the type and location of tissue to be treated, the size of the tissue volume to be treated, etc. By way of example only, in one embodiment, the elongate body can be a thin-walled stainless steel needle between about 16- and about 18-gauge (i.e., an outer diameter of about 1.27 millimeters to about 1.65 millimeters), and having a length L (e.g., as shown inFIG. 2 ) that is approximately 25 cm. Theelongate body 102 can include a pointeddistal tip 104 configured to puncture tissue to facilitate introduction of the device into a target volume of tissue, however, in other embodiments the tip can be blunt and can have various other configurations. Theelongate body 102 can be formed from a conductive material such that the elongate body can conduct electrical energy along its length to one or more ablation elements located along a distal portion of the elongate body.Emitter electrode 105 is an example of an ablation element capable of delivering RF energy from the elongate body. - In some embodiments, the
emitter electrode 105 can be a portion of theelongate body 102. For example, theelongate body 102 can be coated in an insulating material along its entire length except for the portion representing theemitter electrode 105. More particularly, in one embodiment, theelongate body 102 can be coated in 1.5 mil of the fluoropolymer Xylan™ 8840. Theelectrode 105 can have a variety of lengths and shape configurations. In one embodiment, theelectrode 105 can be a 4 mm section of a tubular elongate body that is exposed to surrounding tissue. Further, theelectrode 105 can be located anywhere along the length of the elongate body 105 (and there can also be more than one electrode disposed along the length of the elongate body). In one embodiment, the electrode can be located adjacent to thedistal tip 104. In other embodiments, the elongate body can be formed from an insulating material, and the electrode can be disposed around the elongate body or between portions of the elongate body. - In other embodiments, the electrode can be formed from a variety of other materials suitable for conducting current. Any metal or metal salt may be used. Aside from stainless steel, exemplary metals include platinum, gold, or silver, and exemplary metal salts include silver/silver chloride. In one embodiment, the electrode can be formed from silver/silver chloride. It is known that metal electrodes assume a voltage potential different from that of surrounding tissue and/or liquid. Passing a current through this voltage difference can result in energy dissipation at the electrode/tissue interface, which can exacerbate excessive heating of the tissue near the electrodes. One advantage of using a metal salt such as silver/silver chloride is that it has a high exchange current density. As a result, a large amount of current can be passed through such an electrode into tissue with only a small voltage drop, thereby minimizing energy dissipation at this interface. Thus, an electrode formed from a metal salt such as silver/silver chloride can reduce excessive energy generation at the tissue interface and thereby produce a more desirable therapeutic temperature profile, even where there is no liquid flow about the electrode.
- The
electrode 105 or other ablation element can include one ormore outlet ports 108 that are configured to deliver fluid from aninner lumen 106 extending through theelongate body 102 into surrounding tissue (as shown by arrows 109). Alternatively, theelectrode 105 can be positioned near one ormore outlet ports 108 formed in theelongate body 102. In many embodiments, it can be desirable to position the electrode adjacent to the one ormore outlet ports 108 to maximize the effect of the flowing fluid on the therapy. Theoutlet ports 108 can be formed in a variety of sizes, numbers, and pattern configurations. In addition, theoutlet ports 108 can be configured to direct fluid in a variety of directions with respect to theelongate body 102. These can include the normal orientation (i.e., perpendicular to the elongate body surface) shown byarrows 109 inFIG. 1 , as well as orientations directed proximally and distally along a longitudinal axis of theelongate body 102, including various orientations that develop a circular or spiral flow of liquid around the elongate body. Still further, in some embodiments, theelongate body 102 can be formed with an open distal end that serves as an outlet port. By way of example, in one embodiment, twenty-four equally-spacedoutlet ports 108 having a diameter of about 0.4 mm can be created around the circumference of theelectrode 105 using Electrical Discharge Machining (EDM). One skilled in the art will appreciate that additional manufacturing methods are available to create theoutlet ports 108. In addition, in some embodiments, the outlet ports can be disposed along a portion of the elongate body adjacent to the electrode, rather than being disposed in the electrode itself. - The
inner lumen 106 that communicates with theoutlet ports 108 can also house aheating assembly 110 configured to heat fluid as it passes through theinner lumen 106 just prior to being introduced into tissue. Detailed discussion of various embodiments of theheating assembly 110 suitable for use in devices and methods of the present invention can be found in related U.S. application Ser. No. 13/445,036, entitled “Methods and Devices for Heating Fluid in Fluid Enhanced Ablation Therapy,” filed concurrently with the present application and incorporated by reference in its entirety above. - The portion of the elongate body located distal to the
electrode 105 or other ablation element can be solid or filled such that theinner lumen 106 terminates at the distal end of theelectrode 105. In one embodiment, the inner volume of the portion of the elongate body distal to the electrode can be filled with a plastic plug that can be epoxied in place or held by an interference fit. In other embodiments, the portion of the elongate body distal to the electrode can be formed from solid metal and attached to the proximal portion of the elongate body by welding, swaging, or any other technique known in the art. - Fluid can be supplied to the
inner lumen 106 andheating assembly 110 from afluid reservoir 112. Thefluid reservoir 112 can be connected to theinner lumen 106 via afluid conduit 114. Thefluid conduit 114 can be, for example, a length of flexible plastic tubing. Thefluid conduit 114 can also be a rigid tube, or a combination of rigid and flexible tubing. - Fluid can be urged from the
fluid reservoir 112 into theinner lumen 106 by apump 116. Thepump 116 can be a syringe-type pump that produces a fixed volume flow with advancement of a plunger (not shown). An example of such a pump is a Model 74900 sold by Cole-Palmer Corporation of Chicago, Ill. Other types of pumps, such as a diaphragm pump, may also be employed. - The
pump 116 can be controlled by a power supply andcontroller 118. The power supply andcontroller 118 can deliver electrical control signals to thepump 116 to cause the pump to produce a desired flow rate of fluid. The power supply andcontroller 118 can be connected to thepump 116 via anelectrical connection 120. The power supply andcontroller 118 can also be electrically connected to theelongate body 102 viaconnection 122, and to acollector electrode 124 viaconnection 126. In addition, the power supply andcontroller 118 can be connected to theheating assembly 110 through a similar electrical connection. - The
collector electrode 124 can have a variety of forms. For example, thecollector electrode 124 can be a large electrode located outside a patient's body. In other embodiments, thecollector electrode 124 can be a return electrode located elsewhere along theelongate body 102, or it can be located on a second elongate body introduced into a patient's body near the treatment site. - In operation, the power supply and
controller 118 can drive the delivery of fluid into target tissue at a desired flow rate, the heating of the fluid to a desired therapeutic temperature, and the delivery of therapeutic ablative energy via the one or more ablation elements, such aselectrode 105. To do so, the power supply andcontroller 118 can itself comprise a number of components for generating, regulating, and delivering required electrical control and therapeutic energy signals. For example, the power supply andcontroller 118 can include one or more frequency generators to create one or more RF signals of a given amplitude and frequency. These signals can be amplified by one or more RF power amplifiers into relatively high-voltage, high-amperage signals, e.g., 50 volts at 1 amp. These RF signals can be delivered to the ablation element via one or moreelectrical connections 122 and theelongate body 102 such that RF energy is passed between theemitter electrode 105 and thecollector electrode 124 that can be located remotely on a patient's body. In embodiments in which the elongate body is formed from non-conductive material, the one or moreelectrical connections 122 can extend through the inner lumen of the elongate body or along its outer surface to deliver current to theemitter electrode 105. The passage of RF energy between the ablation element and thecollector electrode 124 can heat the tissue surrounding theelongate body 102 due to the inherent electrical resistivity of the tissue. The power supply andcontroller 118 can also include a directional coupler to feed a portion of the one or more RF signals to, for example, a power monitor to permit adjustment of the RF signal power to a desired treatment level. - The
elongate body 102 illustrated inFIG. 1 can be configured for insertion into a patient's body in a variety of manners.FIG. 2 illustrates one embodiment of amedical device 200 having anelongate body 202 disposed on a distal end thereof configured for laparoscopic or direct insertion into a target area of tissue. In addition to theelongate body 202, thedevice 200 can include ahandle 204 to allow an operator to manipulate the device. Thehandle 204 can include one or moreelectrical connections 206 that connect various components of the elongate body (e.g., the heating assembly and ablation element 205) to, for example, the power supply andcontroller 118 described above. Thehandle 204 can also include at least onefluid conduit 208 for connecting a fluid source to thedevice 200. - While
device 200 is one exemplary embodiment of a medical device that can be adapted for use in fluid enhanced ablation, a number of other devices can also be employed. For example, a very small elongate body can be required in treating cardiac dysrhythmias, such as ventricular tachycardia. In such a case, an appropriately sized elongate body can be, for example, disposed at a distal end of a catheter configured for insertion into the heart via the circulatory system. In one embodiment, a stainless steel needle body between about 20- and about 25-gauge (i.e., an outer diameter of about 0.5 millimeters to about 0.9 millimeters) can be disposed at a distal end of a catheter. The catheter can have a variety of sizes but, in some embodiments, it can have a length of about 120 cm and a diameter of about 8 French (“French” is a unit of measure used in the catheter industry to describe the size of a catheter and is equal to three times the diameter of the catheter in millimeters). - Therapeutic Treatment Using Fluid Enhanced Ablation
- Ablation generally involves the application of high or low temperatures to cause the selective necrosis and/or removal of tissue. There is a known time-temperature relationship in the thermal destruction of tissue accomplished by ablation. A threshold temperature for causing irreversible thermal damage to tissue is generally accepted to be about 41° Celsius (C.). It is also known that the time required to achieve a particular level of cell necrosis decreases as the treatment temperature increases further above 41° C. It is understood that the exact time/temperature relationship varies by cell type, but that there is a general relationship across many cell types that can be used to determine a desired thermal dose level. This relationship is commonly referred to as an equivalent time at 43° C. expressed as:)
-
t eq.43° C. =∫R (T(t)−43°) dt (1) - where T is the tissue temperature and R is a unit-less indicator of therapeutic efficiency in a range between 0 and 5 (typically 2 for temperatures greater than or equal to 43° C., zero for temperatures below 41° C., and 4 for temperatures between 41 and 43° C.), as described in Sapareto S. A. and W. C. Dewey, Int. J. Rad. Onc. Biol. Phys. 10(6):787-800 (1984). This equation and parameter set represents just one example of the many known methods for computing a thermal dose, and any of methodology can be employed with the methods and devices of the present invention. Using equation (1) above, thermal doses in the range of teq,43° C.=20 minutes to 1 hour are generally accepted as therapeutic although there is some thought that the dose required to kill tissue is dependent on the type of tissue. Thus, therapeutic temperature may refer to any temperature in excess of 41° C., but the delivered dose and, ultimately, the therapeutic effect are determined by the temporal history of temperature (i.e., the amount of heating the tissue has previously endured), the type of tissue being heated, and equation (1). For example, Nath, S. and Haines, D. E., Prog. Card. Dis. 37(4):185-205 (1995) (Nath et al.) suggest a temperature of 50° C. for one minute as therapeutic, which is an equivalent time at 43° C. of 128 minutes with R=2. In addition, for maximum efficiency, the therapeutic temperature should be uniform throughout the tissue being treated so that the thermal dose is uniformly delivered.
-
FIG. 3 illustrates the performance profiles of several ablation techniques by showing a simulated temperature achieved at a given distance from an ablation element, such aselectrode 105. Thefirst profile 302 illustrates the performance of RF ablation without the use of fluid enhancement. As shown in the figure, the temperature of the tissue falls very sharply with distance from the electrode. This means that within 10 millimeters of the ablation element the temperature of the tissue is still approximately body temperature (37° C.), far below the therapeutic temperature of 50° C. discussed above. Furthermore, very close to the ablation element the temperature is very high, meaning that the tissue will more quickly desiccate, or dry up, and char. Once this happens, the impedance of the tissue rises dramatically, making it difficult to pass energy to tissue farther away from the ablation element. - A second
tissue temperature profile 304 is associated with a second prior art system similar to that described in U.S. Pat. No. 5,431,649. In this second system, an electrode is inserted into tissue and imparts a 400 kHz RF current flow of about 525 mA to heat the tissue. Body temperature (37° C.) saline solution is simultaneously injected into the tissue at a rate of 10 ml/min. The resultingtissue temperature profile 304 is more uniform thanprofile 302, but the maximum temperature achieved anywhere is approximately 50° C. Thus, thetemperature profile 304 exceeds the generally accepted tissue damaging temperature threshold specified for one minute of therapy in only a small portion of the tissue. As described above, such a small temperature increment requires significant treatment time to achieve any therapeutically meaningful results. - A third
tissue temperature profile 306 is achieved using the teachings of the present invention. In the illustrated embodiment, an electrode formed from silver/silver chloride is inserted into tissue and imparts a 480 kHz RF current flow of 525 mA to heat the tissue. Saline solution heated to 50° C. is simultaneously injected into the tissue at a rate of 10 ml/min. The resultingtemperature profile 306 is both uniform and significantly above the 50° C. therapeutic threshold out to 15 millimeters from the electrode. Moreover, because the temperature is uniform within this volume, the thermal dose delivered is also uniform through this volume. - The uniform temperature profile seen in
FIG. 3 can be achieved by the introduction of heated fluid into the target tissue during application of ablative energy. The fluid convects the heat deeper into the tissue, thereby reducing the charring and impedance change in tissue that occurs near the ablation element, as shown inprofile 302. Further, because the fluid is heated to a therapeutic level, it does not act as a heat sink that draws down the temperature of the surrounding tissue, as seen inprofile 304. Therefore, the concurrent application of RF energy and perfusion of heated saline solution into the tissue eliminates the desiccation and/or vaporization of tissue adjacent to the electrode, maintains the effective tissue impedance, and increases the thermal transport within the tissue being heated with RF energy. The total volume of tissue that can be heated to therapeutic temperatures, e.g., greater than 41° C., is thereby increased. For example, experimental testing has demonstrated that a volume of tissue having a diameter of approximately 8 centimeters (i.e., a spherical volume of approximately 156 cm3) can be treated in 5 minutes using the fluid enhanced ablation techniques described herein. By comparison, conventional RF can only treat volumes having a diameter of approximately 3 centimeters (i.e., a spherical volume of approximately 14 cm3) in the same 5-minute time span. - In addition, fluid enhanced ablation devices according to the present invention have a greater number of parameters that can be varied to adjust the shape of the treatment profile according to the tissue being treated. For example, when using the SERF ablation technique, an operator or control system can modify parameters such as saline temperature (e.g., from about 40° C. to about 80° C.), saline flow rate (e.g., from about 0 ml/min to about 20 ml/min), RF signal power (e.g., from about 0 W to about 100 W), and duration of treatment (e.g., from about 0 minutes to about 10 minutes) to adjust the
temperature profile 306. In addition, different electrode configurations can also be used to vary the treatment. For example, although theemitter electrode 105 illustrated inFIG. 1 is configured as a continuous cylindrical band adapted for a mono-polar current flow, the electrode can also be formed in other geometries, such as spherical or helical, that form a continuous surface area, or the electrode may have a plurality of discrete portions. The electrodes may also be configured for bipolar operation, in which one electrode (or a portion of an electrode) acts as a cathode and another electrode (or portion thereof) acts as an anode. - A preferred fluid for use in the SERF ablation technique is sterile normal saline solution (defined as a salt-containing solution). However, other liquids may be used, including Ringer's solution, or concentrated saline solution. A fluid can be selected to provide the desired therapeutic and physical properties when applied to the target tissue and a sterile fluid is recommended to guard against infection of the tissue.
- Treatment Zone Development and Monitoring
- In fluid enhanced ablation therapy, ablative energy generally expands from an ablation element, such as
emitter electrode 105, in a roughly spherical pattern. This, in turn, creates ablation therapy treatment zones, volumes, or regions (i.e., regions that receive a therapeutic dose of ablative energy by reaching a therapeutic temperature for a period of time, as discussed above) that have a roughly spherical shape. The diameter of the spherical treatment zone can increase as the treatment time is lengthened. - One embodiment of this behavior is illustrated in
FIG. 4 . The figure shows one embodiment of anablation device 400 that includes anelongate body 402 having adistal tip 404 and anemitter electrode 405. A plurality ofoutlet ports 408 can be positioned along an outer surface of theemitter electrode 405 and can be configured to deliver fluid into the tissue surrounding theelongate body 402. As heated fluid is delivered from theoutlet ports 408 and ablative energy is delivered into the tissue via theemitter electrode 405, a treatment zone develops at a first time that is defined by the dotted lines labeled T1. While drawn as a two-dimensional circle, one skilled in the art will appreciate that the treatment zone represented is roughly spherical in shape. As the treatment time increases, so too does the diameter of the treatment zone, until it reaches the dotted lines labeled T2 at a second time that is greater than the first time. Similarly, at a third time greater than the second time, the treatment zone can reach the dotted lines labeled T3. - The propagation of the treatment zone over time can be affected by a variety of factors. These can include factors related to the tissue being treated (e.g., features, tissue type, amount of heating already endured, etc.) as well as factors related to the therapy operating parameters (e.g. temperature of fluid being delivered, flow rate of fluid being delivered, level of ablative energy being delivered, etc.). As mentioned above, fluid enhanced ablation has a greater number of tunable operating parameters than conventional ablation therapy techniques, and all of these can affect the development of the treatment zone.
-
FIG. 5 illustrates a few examples of treatment profiles that can be achieved by adjusting various operating parameters of the fluid enhanced ablation system. For example, if a volume of tissue is to be treated with fluid enhanced ablation at a therapeutic temperature of T0 for a period of time, initial operating parameters may produce aninitial treatment profile 502. As shown in the figure, thetreatment profile 502 does not bring tissue located a distance away from the ablation element above the therapeutic temperature. To tune the system, an operator or control system can, for example, increase the ablative energy level being applied to the tissue. This can result in thesecond treatment profile 504. Thesecond treatment profile 504 delivers therapeutic heat farther into tissue, but also delivers significantly more heat into tissue located closer to the ablation element. This additional heat may be undesirable and can lead to charring of the tissue. In response, the operator or control system can further adjust the operating parameters of the system by, for example, increasing the flow rate of therapeutically heated saline being introduced into the tissue at or immediately adjacent to the ablative element. Doing so can have the effect of smoothing out the temperature spike seen in thetreatment profile 504, producing thetreatment profile 506. This treatment profile brings tissue to a therapeutic temperature over the largest distance from the ablation element and avoids an undesirable temperature spike closer to the ablation element. - It is often desirable to produce the most uniform treatment profile possible within the treatment volume wherein all portions of the volume receive the same therapeutic dose of ablative energy. In
FIG. 5 , such a treatment profile can be shown by a horizontal line across the depth of the treatment zone. Fluid enhanced ablation approximates this ideal scenario far more closely than other ablation techniques because it more effectively distributes thermal energy into tissue and provides more flexibility in shaping the treatment profile to accommodate variations due to operating parameters or anatomical features or properties. - However, in order to provide for effective tuning of fluid enhanced ablation operating parameters, it can be desirable to gather feedback regarding the temperature of tissue at various locations throughout a targeted treatment volume. In U.S. Pat. No. 6,328,735 incorporated by reference above, an elongate body for use in fluid enhanced ablation is disclosed having a single temperature sensor located immediately adjacent to the ablation element (i.e., the emitter electrode). This sensor location, however, does not report the temperature of tissue at locations a distance apart, i.e., remote, from the ablation element.
- Accordingly, fluid enhanced ablation systems can include one or more temperature sensors that are introduced at various locations a distance apart from the ablation element to provide a more accurate assessment of the propagation of the thermal energy being delivered into tissue, thereby allowing a more accurate calculation of the therapeutic dosage and more control over the ablation therapy generally.
- One embodiment of a fluid enhanced ablation device having an additional temperature sensor is illustrated in
FIG. 6 . As shown, thedevice 600 includes anelongate body 602 having an inner lumen (not shown) extending therethrough. Theelongate body 602 can have a pointeddistal tip 604 to facilitate entry into tissue, though other shapes can be used, as described above. Theelongate body 602 also includes anablation element 605 having one ormore outlet ports 608 formed therein that are in fluid communication with the inner lumen extending through theelongate body 602. - In use, the
elongate body 602 can be inserted into alesion 610 or other targeted volume of tissue and positioned such that theablation element 605 is located substantially in the center of thelesion 610. Ablative energy and heated fluid can then be delivered simultaneously into the surrounding tissue to begin therapy (in some embodiments, however, the delivery of heated fluid alone can produce the desired therapeutic result). The dotted lines T1, T2, T3 indicate the portion of the lesion that receives a therapeutic dose of ablative energy at times T1, T2, T3, where T3 is greater than T2, and T2 is greater than T1. - The
elongate body 602 also includes two temperature sensors located along the length of the elongate body to measure the temperature of adjacent tissue. Afirst temperature sensor 612 can be located immediately adjacent to theablation element 605 in either a proximal or distal direction. Thesecond temperature sensor 614, by contrast, can be located a distance apart from theablation element 605 along the length of theelongate body 602. Thesecond temperature sensor 614 can thus be configured to measure the temperature of adjacent tissue that is located a distance away from theablation element 605 and from the tissue immediately adjacent to the ablation element. In some embodiments, the location of thesecond temperature sensor 614 can be selected such that the second temperature sensor is positioned at the edge of the desired treatment zone (e.g., lesion 610). In other embodiments, however, thesecond temperature sensor 614 can be positioned at a location between the ablation element and the edge of the desired treatment zone. In certain embodiments, thesecond temperature sensor 614 can be positioned at least about 5 mm from theablation element 605 so that the temperature measurement from the second temperature sensor remains distinct from the measurement of thefirst temperature sensor 612. - Moreover, the
second temperature sensor 614 can be positioned at a location proximal or distal to the ablation element. In some embodiments, however, it can be preferable to position thesecond temperature sensor 614 proximal to theablation element 605, as doing so requires a shallower insertion of theelongate body 602 into tissue. For example, if thesecond temperature sensor 614 is located distal to theablation element 605, theelongate body 602 must be inserted into, for example, thelesion 610 to a depth greater than the configuration shown inFIG. 6 so that theablation element 605 is positioned at the center of thelesion 610 and thesecond temperature sensor 614 is positioned near the periphery of the lesion opposite from its illustrated position in the figure. - As mentioned above, in some embodiments the
second temperature sensor 614 can be positioned such that it is located near the periphery of the targeted treatment volume, as shown inFIG. 6 . This configuration can be advantageous because thesecond temperature sensor 614 can be used to provide an indication that therapy can be terminated. That is, once a temperature sensor located at the periphery of a targeted treatment volume indicates that a therapeutic dose of energy has been delivered at the periphery (e.g., a threshold temperature is reached for a given amount of time), an operator or control system can terminate the ablation therapy. In other embodiments, the temperature measured by thesecond temperature sensor 614 can be compared to the temperature measured by thefirst temperature sensor 612 to determine if the treatment volume has received a therapeutic dose of ablative energy. - Placing the
second temperature sensor 614 at the periphery of a targeted treatment volume, such aslesion 610, can be accomplished in a variety of manners. For example, the targeted treatment volume can be imaged in advance of ablation therapy using any number of medical imaging technologies such as ultrasound, Magnetic Resonance Imaging (MRI), etc. Following imaging, an operator can select an appropriately sized elongate body having a distance between the first andsecond temperature sensors lesion 610. Alternatively, and as is explained in more detail below, thesecond temperature sensor 614 can be configured to slide or otherwise adjust along the length of theelongate body 602. In such an embodiment, the position of thesecond temperature sensor 614 can be adjusted following a determination, via medical imaging or other measurement technology, of the size of the targeted treatment volume. - In other embodiments, a plurality of additional temperature sensors can be placed along the length of the elongate body to provide more detailed and precise feedback regarding the heating of tissue surrounding the elongate body. This can be accomplished, for example, by placing a plurality of temperature sensors in a line extending proximally from the
first temperature sensor 612 to thesecond temperature sensor 614. One skilled in the art will appreciate that the additional temperature sensors can provide additional observation points that allow more precise tracking of the propagation of thermal energy from theablation element 605. - The concepts described above regarding the placement of one or more additional temperature sensors along the elongate body at locations proximal and remote from the ablation element can also be applied in the distal direction.
FIG. 7 illustrates one embodiment of a fluid enhanced ablation device having remotely located temperature sensors positioned both proximally and distally from an ablation element. Similar to the devices described above, thedevice 700 can include anelongate body 702 having a proximal end and adistal tip 704, as well as an ablation element 705 (e.g., an emitter electrode) with one ormore outlet ports 708 formed therein to allow fluid to pass from an inner lumen of theelongate body 702 into surrounding tissue. - In addition, the elongate body can include a plurality of temperature sensors including first, second, and third
proximal temperature sensors ablation element 705. Thefirst temperature sensor 710 can be located a first distance away from theablation element 705. Thesecond temperature sensor 711 can be located a second distance away from theablation element 705 that is greater than the first distance. Similarly, thethird temperature sensor 712 can be located a third distance away from theablation element 705 that is greater than the second distance. - In a symmetrical arrangement, the elongate body can also include first, second, and third
distal temperature sensors ablation element 705 in a similar spacing arrangement astemperature sensors - As shown in the figure, the plurality of temperature sensors can be positioned in a single line, e.g., extending along a longitudinal axis of the elongate body. In other embodiments, however, the temperature sensors can be positioned at various locations around the circumference of the elongate body, thereby forming a corkscrew or spiral pattern. Furthermore, the elongate body can include additional lines of temperature sensors similar to the sensors shown in
FIG. 7 , each of which can be positioned at a different location around the circumference of the elongate body. These additional temperature sensors can provide still greater detail of the temperature in the tissue surrounding theelongate body 702. - In use, the device illustrated in
FIG. 7 can be positioned in a treatment volume (e.g., lesion 709) such that theablation element 705 is located approximately in the center of the volume. The first, second, and thirdproximal temperature sensors distal temperature sensors elongate body 702 and the spacing of the temperature sensors along the elongate body can be selected according to the size of thelesion 709, which can be imaged before ablation therapy using any of the medical imaging technologies discussed above or otherwise known in the art. - After the
elongate body 702 is positioned within thelesion 709, therapy can begin by delivering therapeutically heated saline alone or in combination with ablative energy from theablation element 705. A control system or operator can monitor the readouts from the plurality of temperature sensors to determine the extent of the therapeutic treatment volume. For example, at a first time T1 the operator or control system can detect a therapeutic temperature from the first proximal anddistal temperature sensors distal temperature sensors distal temperature sensors distal temperature sensors lesion 709 shown in the figure. This can be done using, for example, ultrasound, MRI, or other imaging technologies. In addition, any of the illustratedproximal temperature sensors distal sensors - In other embodiments, the
device 700 can be configured such that the most proximal and most distal temperature sensors (e.g.,sensors 712, 715) are positioned outside of the desired treatment volume (e.g., lesion 709) while an inner set of temperature sensors (e.g.,sensors 711, 714) are positioned at the edge of the treatment volume and one or more additional temperature sensors (e.g.,sensors 710, 713) are within the treatment volume. In such a configuration, the temperature sensors located at the edge of the treatment volume can indicate when therapy is complete, while the inner temperature sensors can monitor the uniformity of temperature within the treatment volume and the temperature sensors positioned outside of the treatment volume can ensure that adjacent tissue does not receive a therapeutic dose of heat. - The devices described above can be formed in a variety of sizes suitable to provide therapy to a wide range of lesions. By way of example only, lesions ranging from 5 mm to 100 mm have been treated using the devices disclosed herein. One skilled in the art will appreciate that the spacing between any temperature sensors included in a device can depend on the size of the device and the size of the lesion or other target volume of tissue being treated. By way of example only, a device configured for use in tumors or other large lesions (e.g., greater than 3 cm in diameter) can have temperature sensors positioned at intervals of about 1 cm to about 5 cm both proximally and distally from an ablation element. By way of further example, smaller devices, such as a catheter-based device configured for use in treating ventricular tachycardia, can have temperature sensors positioned at intervals of about 2 mm to about 3 mm both proximally and distally from an ablation element.
-
FIG. 8 illustrates an exploded view showing one embodiment of the construction of a fluidenhanced ablation device 800. Anelongate body 802 is shown having aninner lumen 806 that houses components configured to deliver therapeutically heated fluid to the surrounding tissue. For example, theinner lumen 806 can include a dual-wire heating assembly 810 that is configured to heat fluid flowing through theinner lumen 806 by passing electrical energy between the two wires and through the fluid. The dual-wire heating assembly 810 can include one ormore spacers 811 configured to hold the two wires of theheating assembly 810 in a substantially fixed geometric relationship with respect to each other and/or theelongate body 802. An exemplary dual-wire heating assembly 810 is described in further detail in U.S. application Ser. No. 13/445,036, entitled “Methods and Devices for Heating Fluid in Fluid Enhanced Ablation Therapy,” filed concurrently with the present application and incorporated by reference above. - As shown in
FIG. 8 , theelongate body 802 can include atemperature sensor 812 embedded in a sidewall of the elongate body. Thetemperature sensor 812 shown is a fine-wire thermocouple known in the art that utilizes different conducting materials to produce a voltage proportional to a temperature difference between the ends of the materials. For example, the thermocouple can include a chromel (Nickel-Chromium alloy)wire 813 and a constantan (Copper-Nickel alloy)wire 814 connected at the location of thethermocouple 812. - The thermocouple or other temperature sensor can be positioned along the
elongate body 802 in a variety of manners. For example, the sensor can be placed on an outer surface of the elongate body and any connecting wires can be run through the elongate body and up theinner lumen 806, or the wire can be run along an outer surface of theelongate body 802. In other embodiments, theelongate body 802 can include outer facing grooves, inner facing grooves, or passages formed through a sidewall thereof (depending on the thickness of the sidewall) adapted to accommodate wires connecting to one or more temperature sensors. In still other embodiments, wireless temperature sensors can be positioned along theelongate body 802 to remove the need to run connecting wires to a proximal end of the elongate body. - In the embodiment shown in
FIG. 8 , thethermocouple temperature sensor 812 is shown embedded in the sidewall of theelongate body 802. By way of example only, thetemperature sensor 812 can be embedded by forming a hole in a sidewall of theelongate body 802, placing the thermocouple junction in the hole, and sealing the wires in place with a conductive epoxy. In one exemplary embodiment, a 0.8 mm diameter hole can be formed in a 25 cm long 16-gauge thin-walled stainless steel elongate body, and a thermocouple formed from 0.08 mm diameter Type E (chromel constantan) wires can be placed in the hole and sealed with epoxy. In other embodiments, however, the thermocouple sensor can be affixed to the inside of a thermally conductive elongate body to detect the temperature in the surrounding tissue through the elongate body. In such embodiments, calibration may be necessary to compensate for the indirect measurement. - The embedding procedure described above places the temperature sensor at one given location along the length of the elongate body. In other embodiments, however, one or more temperature sensors can be configured to be adjustable along the length of the elongate body. This can be accomplished, for example, by placing one or more temperature sensors in grooves or tracks running along the length of the elongate body. Alternatively, one or more temperature sensors can be placed on one or more bands disposed around the elongate body that can be slidably moved up and down the length of the elongate body. In still other embodiments, the elongate body can be formed with a plurality of recesses configured to removably receive a temperature sensor module. The recesses can be formed at a variety of spaced apart positions such that a user can select the most appropriate recess for temperature sensor placement prior to ablation therapy. The remaining recesses can be left empty or filled with a plug to maintain the smooth profile of the elongate body. Regardless of the particular implementation, connecting wires from any temperature sensors can be run along an outer surface of the elongate body or can extend into the inner lumen at a particular location along the elongate body. Still further, in some embodiments, wireless temperature sensors can be employed to remove the need for connecting wires.
- The
inner lumen 806 of theelongate body 802 can also include an insulatingtube 816 that houses the dual-wire heating assembly 810 and that contains any fluid flowing through theinner lumen 806. The insulatingtube 816 can prevent the temperature of the flowing fluid from affecting the temperature measured by thethermocouple 812. The insulatingtube 816 can be formed from any number of thermally insulating materials and, in one embodiment, can be formed from a polymer such as polyimide. - In some embodiments, the insulating
tube 816 can be constructed so as to utilize the relatively efficient thermal insulating properties of air. For example,FIG. 9A illustrates one embodiment of an insulatingtube 916 having acentral lumen 906 and a plurality ofsecondary lumens 918 formed in a sidewall thereof. Such an insulatingtube 916 can be formed, for example, by extrusion methods known in the art. In some embodiments that include the insulatingtube 916, the wires associated with one or more of the thermocouples can be run outside thetube 916 or through one of thesecondary lumens 918. - In another embodiment illustrated in
FIG. 9B , an insulatingtube 920 can be formed with one or more features configured to create an air gap between the tube and the sidewalls of theelongate body 802. The insulatingtube 920 can include, for example, a plurality oftabs 922 running longitudinally along the tube and extending laterally therefrom. When placed within theinner lumen 806 of theelongate body 802, thetabs 922 can prevent the insulatingtube 920 from directly contacting the sidewalls of the elongate body. As a result, anair gap 924 can be created between the thermocouple 812 or other temperature sensor and the insulatingtube 920 containing heated fluid for use in fluid enhanced ablation. - The degree of thermal isolation of the flowing saline from the one or more temperature sensors can vary according to the particular design of a given device. In some embodiments, it can be desirable to achieve a particular degree of thermal isolation. This can be quantified, for example, as a difference between a first temperature recorded with no fluid flow through the inner lumen and a second temperature recorded with room temperature saline flowing through the inner lumen. In some embodiments, devices can be configured to limit this difference to 2° C. or less.
- The flowing fluid utilized during ablation therapy is not the only thermal interference that can affect the one or more temperature sensors. The elongate body itself can, in some embodiments, affect the temperature measured by the
thermocouple 812 or other temperature sensor. For example, in embodiments in which theelongate body 802 is formed from a conducting material, the elongate body itself is likely to conduct heat along a thermal gradient, thereby “flattening” the gradient that might otherwise be observed in the tissue. This can result in the elongate body being relatively cold while the surrounding tissue is hot at some locations, and vice versa at other locations. This can, in turn, result in the measurement of an incorrect temperature or temperature gradient by the one or more temperature sensors positioned along the length of the elongate body. - The influence of the elongate body on temperatures measured by the one or more temperature sensors disposed thereon can be managed using a variety of techniques. For example, the material, cross-sectional size, and sidewall thickness of the elongate body can be selected so as to match the thermal conductivity of the surrounding tissue. This, however, can be a costly, difficult, and time-consuming calibration to make. Alternatively, a variety of methods can be employed to compensate for any thermal interference from the elongate body. These include mathematical analysis to correct for the influence, empirical observation to calibrate the sensors, or controlled experiments to characterize the effect of the elongate body on the temperature measurements.
- For example, in some embodiments, it can be desirable to control the error introduced by the elongate body to be below a particular threshold value. For example, in one embodiment, the elongate body and one or more temperature sensors can be calibrated such that the temperature at a position located a distance apart from an ablation element is within 5° C. of the true temperature within the surrounding tissue at the same position.
- In still other embodiments, however, the elongate body may not introduce the thermal interference discussed above. For example, in embodiments in which the elongate body is formed from a non-conducting material such as a polymer, the temperature of the elongate body may not affect the readings of any temperature sensors positioned along the elongate body.
- The embodiments described above utilize one or more temperature sensors disposed along the elongate body at locations remote from an ablation element to measure the temperature of tissue surrounding the elongate body. As such, the one or more temperature sensors generally provide readings along a longitudinal axis of the elongate body. In other embodiments, however, one or more temperature sensors can be located remotely from both the ablation element and the elongate body itself Positioning one or more temperature sensors at various locations within the volume of tissue surrounding the elongate body and ablation element can provide data regarding the three-dimensional propagation of thermal energy within the surrounding tissue.
-
FIG. 10 illustrates one embodiment of a fluid enhanced ablation device including anelongate body 1102 having adistal tip 1104, anablation element 1105, and one ormore outlet ports 1108 formed in the elongate body to deliver fluid from aninner lumen 1106 to tissue surrounding the elongate body. The device also includes a plurality oftemperature sensors 1112 each located at a distal end of anelastic tine 1114 that is configured to extend from theelongate body 1102 into surrounding tissue. The elastic tines can be formed from a variety of materials and, in one embodiment, are formed from Nitinol (Nickel-Titanium alloy). The temperature sensors disposed at the distal ends of the elastic tines can be any of the temperature sensors discussed above, for example, fine-wire thermocouples or wireless sensors. If a wired temperature sensor is used, the tines can be formed with an inner lumen that accommodates the wired connection, or the wires can be run along an outer surface of the tine and affixed thereto using, for example, a thin polymer coating. - In use, the
tines 1114 can be initially retracted into theelongate body 1102, with thesensors 1112 disposed within theelongate body 1102, such that they do not interfere with insertion of the elongate body into the desired treatment volume of tissue. Thetines 1114 can be housed within passages formed in the sidewall of the elongate body (shown as dotted lines inFIG. 10 ), or can be housed within theinner lumen 1106 of the elongate body. After theelongate body 1102 is positioned within the treatment volume (e.g., positioned such that theablation element 1105 is located generally in the center of the treatment volume), thetines 114 can be extended from outlet ports formed in theelongate body 1102 and can assume, for example, the configuration shown inFIG. 10 . Thetemperature sensors 1112 located at the distal end of eachtine 1114 can detect the temperature of tissue and determine when a therapeutic dose of ablative energy has been delivered to the entire treatment volume. Following therapy, the tines can be retracted into theelongate member 1102 prior to removing or repositioning theelongate member 1102. - Any number of
tines 1114 can be utilized, and the tines can be preconfigured to assume a particular shape within the surrounding tissue using the shape memory characteristics of particular materials such as Nitinol. As a result, a series oftines 1114 can be used to form, for example, a spherical detection pattern surrounding theelongate body 1102. A spherical pattern of temperature sensors can allow a control system or operator to more precisely and accurately determine when a desired treatment volume has received a therapeutic dose of ablative energy. - In addition to providing three-dimensional data regarding the temperature of tissue surrounding the
elongate body 1102, the physical separation from the elongate body provided by theelastic tines 1114 can also substantially eliminate the thermal influence of the elongate body and/or flowing fluid discussed above. Accordingly, in some embodiments, shorter elastic tines can be employed to provide thermal isolation while maintaining the proximity of the temperature sensors to the elongate body. An exemplary embodiment is illustrated inFIG. 11 , which shows the use oftemperature sensors 1212 in combination with very shortelastic tines 1214. Moreover, the elastic tines shown inFIGS. 10 and 11 can be combined with any of the previously discussed embodiments to create devices having a plurality of temperature sensors positioned both along an axis of the elongate body and in the tissue surrounding the elongate body. - Still further, each tine can vary in length such that a device can have one or more longer tines and one or more shorter tines. Such a configuration can allow a device to obtain temperatures at a variety of distances from an ablation element or therapeutically heated saline source. Any device incorporating retractable tines with temperature sensors disposed thereon can also include an actuator configured to deploy the tines from the
elongate body 1102. Exemplary actuator mechanisms can include a sliding lever, a trigger, etc. Each tine can have its own actuator mechanism or a single mechanism can be used to control and deploy a plurality of tines. -
FIG. 12 illustrates another embodiment of anablation device 1300 having one or more temperature sensors located a distance apart from an ablation element. The device inFIG. 12 is divided into portions by one or more baffling members. In the illustrated embodiment, the device is divided into a firstdistal section 1302 a and a secondproximal section 1302 b by abaffling element 1303. Thebaffling element 1303 can be an inner wall that separates the inner lumen of thefirst section 1302 a of the elongate body from the inner lumen of thesecond section 1302 b of the elongate body. - Each
section emitter electrode 1305 a, 1305 b, as well as one ormore outlet ports elongate body 1302 and/oremitter electrode 1305 a, 1305 b that are in fluid communication with the inner lumen of each section. Thesections more temperature sensors elongate body 1302. The temperature sensors can be implemented according to any of the teachings of the present invention and, in some embodiments, the sensors can be fine-wire chromel-constantan thermocouples embedded in a hole formed in the sidewall of theelongate body 1302. Thetemperature sensors elongate body 1302 but, in some embodiments, can be positioned symmetrically with respect to, i.e., at an equal distance away from, theablation elements 1305 a, 1305 b. This arrangement can allow for a more accurate measurement of the uniformity of expansion of the treatment zone. - One benefit of the
device 1300 illustrated inFIG. 12 is the flexibility provided to dynamically alter the therapy delivered in response to the temperatures detected by thesensors FIG. 13 shows simulated temperature measurements for the twotemperature sensors temperature sensor 1304 a during fluid enhanced ablation therapy, and the dashed line represents the temperatures recorded bytemperature sensor 1304 b. The initial conditions at the beginning of therapy are identical, i.e., the same amount of ablative energy is being delivered from bothablation elements 1305 a, 1305 b, and the fluid is being delivered from bothsections FIG. 13 clearly shows that uneven heating is occurring in the tissue surrounding theelongate body 1302. Specifically, the tissue surroundingtemperature sensor 1304 b is not heating to the same therapeutic level as the tissue surroundingtemperature sensor 1304 a. Accordingly, at time T1 shown in the figure, the operating parameters of the ablation therapy are altered. Any or all of the following steps can be taken: (1) the level of ablative energy can be increased in ablation element 1305 b, (2) the flow rate of fluid fromsection 1302 b can be increased, (3) the temperature of the fluid fromsection 1302 b can be increased, (4) the level of ablative energy can be decreased inablation element 1305 a, (5) the flow rate of fluid fromsection 1302 a can be decreased or (6) the temperature of fluid from second 1302 a can be decreased or the flow rate can be increased and the temperature decreased (to essentially urge the heated fluid fromsection 1302 b toward thetemperature sensor 1304 b). - As the example above illustrates, there are a variety of operating parameters for fluid enhanced ablation therapy that can be altered to adjust the therapy delivered to a target volume of tissue. These adjustments can be performed manually by an operator viewing the detected temperatures, or the adjustments can be made automatically by, for example, a control system monitoring the temperature sensors and controlling the therapy operating parameters.
-
FIG. 14 illustrates a semi-transparent view of the device ofFIG. 12 and shows one embodiment of the internal construction of the elongate body divided into a plurality of sections by one or morebaffling members 1303. As shown in the figure, the inner lumen ofsection 1302 a can be separated fromsection 1302 b by the bafflingmember 1303. Thebaffling member 1303 can be constructed in a variety of manners. For example, the baffling member can be an integrated portion of theelongate body 1302, or it can be a separate component secured in theinner lumen 1506 of theelongate body 1302 by an adhesive or other retaining component or material. Thebaffle 1303 can be formed, for example, from a plastic or other suitable material. - The
baffling element 1303 can further include one or more lumens formed therein that are each configured to receive a cannula, such ascannula 1510 a. Thecannula 1510 a can be formed from metal, plastic, or plastic having a metal lining, and can include an inner lumen that provides a fluid passageway to the proximal end of thedevice 1300 through any intervening baffles (e.g., the baffle 1303) and sections (e.g., thesecond section 1302 b). The inner lumen of thecannula 1510 a is not in fluid communication with the inner lumen of any other section (e.g.,section 1302 b). This allows, for example, fluid to be delivered intosection 1302 a separately from the fluid delivered tosection 1302 b, e.g., separate fluid sources can be connected to each section, or the sections can each independently receive fluid from a single common source. Theinner lumen 1506 can also include additional cannulas configured to deliver fluid to other sections of thedevice 1300. For example, theinner lumen 1506 can include acannula 1510 b configured to deliver fluid from a proximal end of thedevice 1300 into thesecond section 1302 b of thedevice 1300. - One skilled in the art will appreciate that the
inner lumen 1506 can include as many cannulas as there are sections in the device. Further, thedevice 1300 can have any number of sections depending on the desired shape of the treatment zone. For example, thedevice 1300 can include two sections as illustrated inFIG. 12 , or can have three or more sections. - In addition, the cannulas can each be rigidly held in position by a spacer element (e.g., an element similar to the
baffle 1303 but also including one or more lumens to allow the passage of fluid around the baffle) or can be allowed to float in theinner lumen 1506. In other embodiments, the cannulas can include features formed on an external surface thereof to prevent contact with other cannulas or the inner walls of theinner lumen 1506. Exemplary features include fins or ribs formed on the outer surface of the cannulas. - Each
cannula cannula single wire cannula cannula wire cannula - The heating assembly described above requires that each
cannula wire cannulas inner lumen 1506 of thedevice 1300. In addition, a thermally insulating material can also be used to coat thecannulas - The
cannulas device 1300. For example, thecannula 1510 a can include a dual-wire thermocouple 1512 a configured to extend beyond the distal end of thecannula 1510 a such that the thermocouple can measure the temperature of fluid within thefirst section 1302 a after it exits the cannula and mixes within theinner lumen 1506 before exiting into the surrounding tissue through theoutlet ports 1308 a. The twothermocouple wires cannula 1510 a back to the proximal end of thedevice 1510 a. The wires can be connected to signal processing electronics as known in the art to determine the temperature of the fluid in thefirst section 1302 a. As shown in the figure, thesecond cannula 1510 b can also include atemperature sensor 1512 b, such as a dual-wire thermocouple formed from twowires sensor 1512 b can similarly be configured to extend beyond the distal end of thecannula 1510 b into thesecond section 1302 b such that the temperature measured by thesensor 1512 b represents the temperature of mixed fluid that is about to be delivered into surrounding tissue viaoutlet ports 1308 b. One skilled in the art will appreciate that a variety of temperature sensors can be employed in the devices of the present invention, including, for example, chromel-constantan fine-wire thermocouples. - Methods of Use
- The various embodiments of the devices and systems disclosed herein can be utilized in a variety of surgical procedures to treat a number of medical conditions. For example, medical devices as disclosed herein can be configured for insertion into a target volume of tissue directly during an open surgical procedure. Alternatively, the medical devices can be configured to be passed through one or more layers of tissue during a laparoscopic or other minimally invasive procedure. Furthermore, the devices can be configured for introduction into a patient via an access port or other opening formed through one or more layers of tissue, or via a natural orifice (i.e., endoscopically). Following delivery to a treatment site, a portion of a surgical device, e.g., a distal portion of the
elongate body 102, can be inserted into a target treatment volume such that an ablation element is disposed within the treatment volume. In some embodiments, the ablation element can be positioned near the center of the treatment volume. If there are any extendable members, such as elastic tines having temperature sensors on a distal end thereof, they can be deployed into the tissue surrounding the elongate member. - Once the device and any associated temperature sensors are positioned within the treatment volume, ablative energy and fluid heated to a therapeutic temperature can be simultaneously delivered through the devices into the treatment volume. In some embodiments, however, therapeutically heated fluid alone can be used without ablative energy. One or more temperature sensors associated with the device can monitor the temperature of tissue at various locations within the target treatment volume. The detected temperatures can be displayed to an operator or monitored by a control program administering the ablation therapy. In some embodiments, the temperatures measured at locations a distance apart from an ablation element can be compared to temperatures measured at or immediately adjacent to the ablation element.
- Any anomalies detected during therapy, such as uneven heating in certain portions of the target volume, can be addressed by the operator or control system. Addressing a detected heating anomaly can involve simply maintaining the therapy until all temperature readings report a uniformly delivered therapeutic dose, or it can require the alteration of other therapy operating parameters such as ablative energy level, fluid flow rate, fluid temperature, etc. These parameters can be adjusted individually or in combination by either an operator or control system, as described above.
- After a period of time, or depending on one or more feedback indications (e.g., a particular indication from all temperature sensors disposed within the treatment volume, or a particular comparison between two or more measurements), the delivery of ablative energy and fluid can be stopped. Any extending temperature sensors can be retracted into the ablation device, and the device can then be removed and/or repositioned if additional therapy is required.
- Sterilization and Reuse
- The devices disclosed herein can be designed to be disposed after a single use, or they can be designed for multiple uses. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present invention.
- For example, the surgical devices disclosed herein may be disassembled partially or completely. In particular, the
elongate body 202 of themedical device 200 shown inFIG. 2 may be removed from thehandle 204, or the entire handle and elongate body assembly may be decoupled from the electrical andfluid connections FIG. 1 . - Preferably, the devices described herein will be processed before surgery. First, a new or used instrument can be obtained and, if necessary, cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and its contents can then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation can kill bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container can keep the instrument sterile until it is opened in the medical facility.
- In many embodiments, it is preferred that the device is sterilized. This can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, steam, and a liquid bath (e.g., cold soak). In certain embodiments, the materials selected for use in forming components such as the elongate body may not be able to withstand certain forms of sterilization, such as gamma radiation. In such a case, suitable alternative forms of sterilization can be used, such as ethylene oxide.
- One skilled in the art will appreciate further features and advantages of the invention based on the above-described embodiments. Accordingly, the invention is not to be limited by what has been particularly shown and described, except as indicated by the appended claims. All publications and references cited herein are expressly incorporated herein by reference in their entirety.
Claims (22)
1. An ablation device, comprising:
a elongate body having a proximal end, a distal end, an inner lumen extending therethrough, and at least one outlet port configured to allow fluid flowing through the inner lumen to be delivered to tissue surrounding the elongate body when the elongate body is introduced into a tissue mass;
at least one ablation element disposed along the elongate body adjacent to the at least one outlet port, the at least one ablation element being configured to heat tissue within a treatment zone surrounding the at least one ablation element when the distal end of the elongate body is introduced into a tissue mass; and
at least one temperature sensor coupled to the elongate member and positioned a distance apart from the at least one ablation element, the at least one temperature sensor being effective to output a measured temperature of tissue spaced a distance apart from tissue adjacent to the at least one ablation element such that the measured temperature indicates whether tissue is being heating to a therapeutic level.
2. The ablation device of claim 1 , wherein the at least one temperature sensor is positioned on the elongate body at a location proximal to the at least one ablation element.
3. The ablation device of claim 1 , wherein the at least one temperature sensor is positioned on the elongate body at a location distal to the at least one ablation element.
4. The ablation device of claim 1 , wherein the at least one temperature sensor comprises a plurality of temperature sensors spaced apart from one another and positioned axially along the elongate body.
5. The ablation device of claim 1 , wherein the elongate body includes a plurality of tines configured to extend outward from the elongate body, and wherein the at least one temperature sensor comprises a plurality of temperature sensors, each of the plurality of tines having one of the plurality of temperature sensors located at a distal tip thereof.
6. The ablation device of claim 5 , wherein each of the plurality of tines has two or more of the plurality of temperature sensors disposed along a length thereof.
7. The ablation device of claim 1 , wherein the at least one temperature sensor comprises a first temperature sensor positioned distal of the at least one ablation element, and a second temperature sensor positioned proximal of the at least one ablation element.
8. The ablation device of claim 1 , wherein the at least one temperature sensor is located on an outer surface of the elongate body.
9. The ablation device of claim 1 , wherein the at least one temperature sensor is located in the inner lumen and contacts an outer wall of the elongate body.
10. The ablation device of claim 1 , wherein the at least one temperature sensor is located in a recess formed in the elongate body.
11. The ablation device of claim 1 , wherein the at least one temperature sensor is thermally isolated from the elongate body.
12. The ablation device of claim 1 , wherein a position of the at least one temperature sensor is adjustable along a length of the elongate member.
13. The ablation device of claim 1 , wherein the at least one temperature sensor comprises a thermocouple.
14. A system for delivering saline enhanced ablation, comprising:
an elongate body having
proximal and distal ends,
an inner lumen extending through the elongate body,
at least one outlet port formed in the elongate body, and
at least one ablation element positioned along the length of a distal portion of the elongate body;
a fluid source in communication with the inner lumen of the elongate body and configured to deliver fluid through the inner lumen such that fluid can flow through the at least one outlet port and be delivered to tissue surrounding the at least one ablation element;
at least one temperature sensor coupled to the elongate body and positioned a distance apart from the at least one ablation element such that the at least one temperature sensor is effective to measure a temperature of tissue spaced a distance apart from tissue adjacent to the at least one ablation element; and
a control unit configured to obtain a temperature of the ablation element and a temperature measured by the at least one temperature sensor;
wherein a temperature measured by the at least one temperature sensor indicates whether tissue within a treatment zone is being heated to a therapeutic level.
15. The system of claim 14 , wherein the control unit is configured to adjust at least one of a flow rate of the fluid flowing through the elongate body, an ablative energy level of the ablation element, and a temperature of the fluid being delivered in response to a temperature measured by the at least one temperature sensor.
16. A method for ablating tissue, comprising:
inserting a needle body into a tissue mass, the needle body having an ablation element disposed thereon and at least one temperature sensor coupled thereto and effective to measure a temperature of the tissue mass at a distance away from tissue immediately adjacent to the ablation element; and
simultaneously delivering fluid through the needle body and into the tissue mass surrounding the needle body and delivering therapeutic energy to the ablation element on the needle body to heat the tissue mass surrounding the needle body;
wherein the at least one temperature sensor measures a temperature of the tissue mass at a distance away from the tissue immediately adjacent to the ablation element.
17. The method of claim 16 , further comprising adjusting at least one of a flow rate of the fluid flowing through the needle body, an ablative energy level of the ablation element, and a temperature of the fluid being delivered.
18. The method of claim 16 , wherein the tissue located the distance away from the tissue immediately adjacent to the ablation source is at the periphery of a desired treatment zone.
19. The method of claim 16 , further comprising ceasing delivery of therapeutic energy once the temperature measured by the at least one temperature sensor reaches a predetermined level.
20. The method of claim 16 , determining a therapeutic dose delivered to the tissue mass based on measurements from the at least one temperature sensor; and
ceasing delivery of therapeutic energy once the thermal dose delivered to the tissue mass reaches a predetermined level.
21. A method for therapeutically treating tissue, comprising:
inserting a needle body into a tissue mass, the needle body having one or more outlet ports formed therein;
delivering fluid heated to a therapeutic temperature into the tissue mass through the one or more outlet ports to heat the tissue mass surrounding the needle body; and
measuring a temperature of the tissue mass at a distance away from the tissue immediately adjacent to the one or more outlet ports.
22. The method of claim 21 , wherein measuring a temperature of the tissue mass comprises detecting the temperature using a temperature sensor disposed along the length of the needle body.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/445,034 US20120277737A1 (en) | 2011-04-12 | 2012-04-12 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US14/202,425 US9730748B2 (en) | 2011-04-12 | 2014-03-10 | Devices and methods for shaping therapy in fluid enhanced ablation |
US15/450,806 US10548654B2 (en) | 2011-04-12 | 2017-03-06 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US15/663,914 US10881443B2 (en) | 2011-04-12 | 2017-07-31 | Devices and methods for shaping therapy in fluid enhanced ablation |
US16/720,581 US11583330B2 (en) | 2011-04-12 | 2019-12-19 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US18/099,508 US20230414267A1 (en) | 2011-04-12 | 2023-01-20 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161474574P | 2011-04-12 | 2011-04-12 | |
US13/445,034 US20120277737A1 (en) | 2011-04-12 | 2012-04-12 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/445,036 Continuation US9138287B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/445,365 Continuation US8702697B2 (en) | 2011-04-12 | 2012-04-12 | Devices and methods for shaping therapy in fluid enhanced ablation |
US14/202,425 Continuation US9730748B2 (en) | 2011-04-12 | 2014-03-10 | Devices and methods for shaping therapy in fluid enhanced ablation |
US15/450,806 Continuation US10548654B2 (en) | 2011-04-12 | 2017-03-06 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120277737A1 true US20120277737A1 (en) | 2012-11-01 |
Family
ID=47006969
Family Applications (19)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/445,373 Active 2033-12-29 US9445861B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for controlling ablation therapy |
US13/445,036 Active 2033-11-21 US9138287B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US13/445,034 Abandoned US20120277737A1 (en) | 2011-04-12 | 2012-04-12 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US13/445,365 Active 2032-09-07 US8702697B2 (en) | 2011-04-12 | 2012-04-12 | Devices and methods for shaping therapy in fluid enhanced ablation |
US13/445,040 Active US8945121B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US14/202,425 Active 2033-03-08 US9730748B2 (en) | 2011-04-12 | 2014-03-10 | Devices and methods for shaping therapy in fluid enhanced ablation |
US14/536,212 Active US9138288B2 (en) | 2011-04-12 | 2014-11-07 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US14/826,549 Active US9877768B2 (en) | 2011-04-12 | 2015-08-14 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US14/826,563 Active 2034-02-02 US10307201B2 (en) | 2011-04-12 | 2015-08-14 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US15/240,693 Expired - Fee Related US9937000B2 (en) | 2011-04-12 | 2016-08-18 | Methods and devices for controlling ablation therapy |
US15/450,806 Active 2033-04-19 US10548654B2 (en) | 2011-04-12 | 2017-03-06 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US15/663,914 Active 2033-05-18 US10881443B2 (en) | 2011-04-12 | 2017-07-31 | Devices and methods for shaping therapy in fluid enhanced ablation |
US15/861,359 Abandoned US20180140345A1 (en) | 2011-04-12 | 2018-01-03 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US15/909,103 Active US10448987B2 (en) | 2011-04-12 | 2018-03-01 | Methods and devices for controlling ablation therapy |
US16/373,104 Active 2032-09-24 US11135000B2 (en) | 2011-04-12 | 2019-04-02 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US16/660,212 Active 2032-07-13 US11871979B2 (en) | 2011-04-12 | 2019-10-22 | Methods and devices for controlling ablation therapy |
US16/720,581 Active 2032-04-16 US11583330B2 (en) | 2011-04-12 | 2019-12-19 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US17/465,780 Active 2032-07-03 US11950829B2 (en) | 2011-04-12 | 2021-09-02 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US18/099,508 Pending US20230414267A1 (en) | 2011-04-12 | 2023-01-20 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/445,373 Active 2033-12-29 US9445861B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for controlling ablation therapy |
US13/445,036 Active 2033-11-21 US9138287B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
Family Applications After (16)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/445,365 Active 2032-09-07 US8702697B2 (en) | 2011-04-12 | 2012-04-12 | Devices and methods for shaping therapy in fluid enhanced ablation |
US13/445,040 Active US8945121B2 (en) | 2011-04-12 | 2012-04-12 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US14/202,425 Active 2033-03-08 US9730748B2 (en) | 2011-04-12 | 2014-03-10 | Devices and methods for shaping therapy in fluid enhanced ablation |
US14/536,212 Active US9138288B2 (en) | 2011-04-12 | 2014-11-07 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US14/826,549 Active US9877768B2 (en) | 2011-04-12 | 2015-08-14 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US14/826,563 Active 2034-02-02 US10307201B2 (en) | 2011-04-12 | 2015-08-14 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US15/240,693 Expired - Fee Related US9937000B2 (en) | 2011-04-12 | 2016-08-18 | Methods and devices for controlling ablation therapy |
US15/450,806 Active 2033-04-19 US10548654B2 (en) | 2011-04-12 | 2017-03-06 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US15/663,914 Active 2033-05-18 US10881443B2 (en) | 2011-04-12 | 2017-07-31 | Devices and methods for shaping therapy in fluid enhanced ablation |
US15/861,359 Abandoned US20180140345A1 (en) | 2011-04-12 | 2018-01-03 | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US15/909,103 Active US10448987B2 (en) | 2011-04-12 | 2018-03-01 | Methods and devices for controlling ablation therapy |
US16/373,104 Active 2032-09-24 US11135000B2 (en) | 2011-04-12 | 2019-04-02 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US16/660,212 Active 2032-07-13 US11871979B2 (en) | 2011-04-12 | 2019-10-22 | Methods and devices for controlling ablation therapy |
US16/720,581 Active 2032-04-16 US11583330B2 (en) | 2011-04-12 | 2019-12-19 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US17/465,780 Active 2032-07-03 US11950829B2 (en) | 2011-04-12 | 2021-09-02 | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US18/099,508 Pending US20230414267A1 (en) | 2011-04-12 | 2023-01-20 | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
Country Status (9)
Country | Link |
---|---|
US (19) | US9445861B2 (en) |
EP (8) | EP3785653A1 (en) |
JP (14) | JP6189826B2 (en) |
KR (9) | KR102283571B1 (en) |
CN (10) | CN103619276B (en) |
AU (7) | AU2012242851A1 (en) |
BR (5) | BR112013026260A2 (en) |
ES (4) | ES2817851T3 (en) |
WO (5) | WO2012142211A1 (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8702697B2 (en) | 2011-04-12 | 2014-04-22 | Thermedical, Inc. | Devices and methods for shaping therapy in fluid enhanced ablation |
US20140236137A1 (en) * | 2013-02-21 | 2014-08-21 | Boston Scientific Scimed, Inc. | Ablation catheter system with wireless radio frequency temperature sensor |
US8926605B2 (en) | 2012-02-07 | 2015-01-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature during tissue ablation |
US8954161B2 (en) | 2012-06-01 | 2015-02-10 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature and detecting tissue contact prior to and during tissue ablation |
US8961506B2 (en) | 2012-03-12 | 2015-02-24 | Advanced Cardiac Therapeutics, Inc. | Methods of automatically regulating operation of ablation members based on determined temperatures |
US9033972B2 (en) | 2013-03-15 | 2015-05-19 | Thermedical, Inc. | Methods and devices for fluid enhanced microwave ablation therapy |
US9277961B2 (en) | 2009-06-12 | 2016-03-08 | Advanced Cardiac Therapeutics, Inc. | Systems and methods of radiometrically determining a hot-spot temperature of tissue being treated |
WO2016164853A1 (en) * | 2015-04-08 | 2016-10-13 | Naya Health, Inc. | Fluid measuring reservoir for breast pumps |
US9510905B2 (en) | 2014-11-19 | 2016-12-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for high-resolution mapping of tissue |
US9517103B2 (en) | 2014-11-19 | 2016-12-13 | Advanced Cardiac Therapeutics, Inc. | Medical instruments with multiple temperature sensors |
US9610396B2 (en) * | 2013-03-15 | 2017-04-04 | Thermedical, Inc. | Systems and methods for visualizing fluid enhanced ablation therapy |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
US9743984B1 (en) | 2016-08-11 | 2017-08-29 | Thermedical, Inc. | Devices and methods for delivering fluid to tissue during ablation therapy |
US9808310B2 (en) | 2005-02-02 | 2017-11-07 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US9861336B2 (en) | 2012-09-07 | 2018-01-09 | Gynesonics, Inc. | Methods and systems for controlled deployment of needle structures in tissue |
US9993178B2 (en) | 2016-03-15 | 2018-06-12 | Epix Therapeutics, Inc. | Methods of determining catheter orientation |
US10022176B2 (en) | 2012-08-15 | 2018-07-17 | Thermedical, Inc. | Low profile fluid enhanced ablation therapy devices and methods |
US10166062B2 (en) | 2014-11-19 | 2019-01-01 | Epix Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
US10617805B2 (en) | 2014-03-20 | 2020-04-14 | Exploramed Nc7, Inc. | Fluid measuring reservoir for breast pumps |
US10888373B2 (en) | 2017-04-27 | 2021-01-12 | Epix Therapeutics, Inc. | Contact assessment between an ablation catheter and tissue |
US10993770B2 (en) | 2016-11-11 | 2021-05-04 | Gynesonics, Inc. | Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data |
US11083871B2 (en) | 2018-05-03 | 2021-08-10 | Thermedical, Inc. | Selectively deployable catheter ablation devices |
US11096760B2 (en) | 2007-10-12 | 2021-08-24 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
US11219483B2 (en) | 2016-11-14 | 2022-01-11 | Gynesonics Inc. | Methods and systems for real-time planning and monitoring of ablation needle deployment in tissue |
US11259825B2 (en) | 2006-01-12 | 2022-03-01 | Gynesonics, Inc. | Devices and methods for treatment of tissue |
US11564735B2 (en) | 2009-02-27 | 2023-01-31 | Gynesonics, Inc. | Needle and fine deployment mechanism |
US11612431B2 (en) | 2017-05-04 | 2023-03-28 | Gynesonics, Inc. | Methods for monitoring ablation progress with doppler ultrasound |
US11918277B2 (en) * | 2018-07-16 | 2024-03-05 | Thermedical, Inc. | Inferred maximum temperature monitoring for irrigated ablation therapy |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9403029B2 (en) * | 2007-07-18 | 2016-08-02 | Visualase, Inc. | Systems and methods for thermal therapy |
US20090093810A1 (en) * | 2007-10-09 | 2009-04-09 | Raj Subramaniam | Electrophysiology Electrodes and Apparatus Including the Same |
US9023030B2 (en) | 2007-10-09 | 2015-05-05 | Boston Scientific Scimed, Inc. | Cooled ablation catheter devices and methods of use |
WO2010054237A1 (en) * | 2008-11-06 | 2010-05-14 | Nxthera, Inc. | Systems and methods for treatment of bph |
WO2016037137A1 (en) | 2014-09-05 | 2016-03-10 | Procept Biorobotics Corporation | Physician controlled tissue resection integrated with treatment mapping of target organ images |
US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
US10588609B2 (en) | 2010-02-04 | 2020-03-17 | Procept Biorobotics Corporation | Gene analysis and generation of stem cell methods and apparatus |
US11490957B2 (en) | 2010-06-16 | 2022-11-08 | Biosense Webster (Israel) Ltd. | Spectral sensing of ablation |
US20140171806A1 (en) * | 2012-12-17 | 2014-06-19 | Biosense Webster (Israel), Ltd. | Optical lesion assessment |
US10314650B2 (en) | 2010-06-16 | 2019-06-11 | Biosense Webster (Israel) Ltd. | Spectral sensing of ablation |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
CN103917200B (en) | 2011-09-13 | 2016-03-30 | 恩克斯特拉公司 | For the system and method for prostate treatment |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
WO2013152119A1 (en) | 2012-04-03 | 2013-10-10 | Nxthera, Inc. | Induction coil vapor generator |
BR112015022358A2 (en) | 2013-03-14 | 2017-07-18 | Nxthera Inc | method for treating abnormal prostate tissue, and, method for treating prostate cancer, and, prostate cancer therapy system |
US9579118B2 (en) * | 2013-05-01 | 2017-02-28 | Ethicon Endo-Surgery, Llc | Electrosurgical instrument with dual blade end effector |
BR112016005036A2 (en) | 2013-09-06 | 2020-04-07 | Procept Biorobotics Corp | automated image guided tissue resection device |
PL2859860T3 (en) * | 2013-10-08 | 2017-12-29 | Erbe Elektromedizin Gmbh | Multifunctional instrument |
EP3079617B1 (en) | 2013-12-10 | 2018-09-26 | Nxthera, Inc. | Vapor ablation systems |
US9968395B2 (en) | 2013-12-10 | 2018-05-15 | Nxthera, Inc. | Systems and methods for treating the prostate |
WO2015153815A1 (en) * | 2014-04-01 | 2015-10-08 | Gregory Brucker | Temperature-responsive irrigated ablation electrode with reduced coolant flow and related methods for making and using |
EP4070744A1 (en) | 2014-06-30 | 2022-10-12 | PROCEPT BioRobotics Corporation | Fluid jet tissue resection and cold coagulation (aquablation) apparatus |
JP6625610B2 (en) | 2014-07-31 | 2019-12-25 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Preparation method of pyrazole |
BR112017004454B1 (en) | 2014-09-05 | 2022-11-01 | Procept Biorobotics Corporation | APPARATUS FOR REMOVING INTACT CELLS FROM A SURGICAL AREA OF A PATIENT |
WO2016123498A1 (en) | 2015-01-29 | 2016-08-04 | Nxthera, Inc. | Vapor ablation systems and methods |
GB2536690B (en) * | 2015-03-26 | 2017-05-10 | Cook Medical Technologies Llc | Medical ablation system and method with reduced stray heating |
AU2016246146B2 (en) * | 2015-04-10 | 2021-03-11 | Angiodynamics, Inc. | System and method for irreversible electroporation with thermally controlled electrodes |
MX2017014287A (en) | 2015-05-11 | 2018-03-07 | Basf Se | Process for preparing 4-amino-pyridazines. |
BR112017024245A2 (en) | 2015-05-13 | 2018-07-17 | Nxthera, Inc. | "method for treating overactive bladder, and steam dispensing system". |
AU2017216082B2 (en) | 2016-02-02 | 2020-12-03 | Basf Se | Catalytic hydrogenation process for preparing pyrazoles |
US11172821B2 (en) | 2016-04-28 | 2021-11-16 | Medtronic Navigation, Inc. | Navigation and local thermometry |
US20170325869A1 (en) * | 2016-05-10 | 2017-11-16 | Covidien Lp | Methods of ablating tissue |
US11445911B2 (en) * | 2016-05-25 | 2022-09-20 | Ikomed Technologies Inc. | System for treating unwanted tissue |
CN106388933B (en) * | 2016-09-14 | 2017-10-10 | 上海睿刀医疗科技有限公司 | Electrode for irreversible electroporation device |
JP6718557B2 (en) * | 2016-10-04 | 2020-07-08 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Ablation catheter tip |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
JP7129980B2 (en) | 2016-12-21 | 2022-09-02 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Steam cautery system and method |
WO2018129180A1 (en) | 2017-01-06 | 2018-07-12 | Dfine, Inc. | Osteotome with a distal portion for simultaneous advancement and articulation |
EP4356944A2 (en) | 2017-01-06 | 2024-04-24 | Nxthera, Inc. | Transperineal vapor ablation systems |
US11147610B2 (en) * | 2017-02-10 | 2021-10-19 | Biosense Webster (Israel) Ltd. | Tissue thickness using pulsed power |
CN106725827B (en) * | 2017-03-02 | 2023-11-17 | 上海伴诚医疗科技有限公司 | Intracranial hematoma removing hemostat and intracranial hematoma removing hemostatic device |
CA3068011A1 (en) * | 2017-06-20 | 2018-12-27 | Aegea Medical Inc. | Induction coil assembly for uterine ablation and method |
US10058372B1 (en) * | 2017-08-17 | 2018-08-28 | John H. Shadduck | Medical ablation devices and methods |
CN109549703B (en) * | 2017-09-25 | 2022-04-01 | 上海微创电生理医疗科技股份有限公司 | Cryoablation system and electrophysiology catheter thereof |
US20190192220A1 (en) * | 2017-12-27 | 2019-06-27 | Medlumics S.L. | Ablation Catheter with a Patterned Textured Active Area |
EP3755254A1 (en) * | 2018-02-21 | 2020-12-30 | Medtronic, Inc. | Focal pulsed field ablation devices and methods |
US20190290300A1 (en) * | 2018-03-23 | 2019-09-26 | SPIRATION, INC., d/b/a OLYMPUS RESPIRATORY AMERICA | Rf bipolar steam generation ablation device |
US11478297B2 (en) * | 2018-03-23 | 2022-10-25 | Avent, Inc. | System and method for controlling energy delivered to an area of tissue during a treatment procedure |
AU2019279011A1 (en) * | 2018-06-01 | 2021-01-07 | Santa Anna Tech Llc | Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems |
US11109999B2 (en) * | 2018-07-27 | 2021-09-07 | Cooltech, Llc | Device for removing heat, energy, and/or fluid from a living mammal |
CN210673430U (en) * | 2018-09-14 | 2020-06-05 | 杭州堃博生物科技有限公司 | Bendable radio frequency ablation catheter |
EP3876856A4 (en) * | 2018-11-08 | 2022-10-12 | Dfine, Inc. | Tumor ablation device and related systems and methods |
WO2020106977A1 (en) * | 2018-11-21 | 2020-05-28 | Buffalo Filter Llc | Method and apparatus for flow |
CN109481013B (en) * | 2018-12-19 | 2021-05-28 | 南京康友医疗科技有限公司 | Microwave ablation device with thermal field monitoring function |
WO2020198150A2 (en) * | 2019-03-22 | 2020-10-01 | Stryker Corporation | Systems for ablating tissue |
US11832873B2 (en) * | 2019-06-14 | 2023-12-05 | Eric Lee | Cannulas for radio frequency ablation |
WO2021062074A1 (en) * | 2019-09-27 | 2021-04-01 | St. Jude Medical, Cardiology Division, Inc. | Irrigated catheter system including fluid degassing apparatus and methods of using same |
JP7335439B2 (en) | 2019-10-28 | 2023-08-29 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | RF electrode cannula |
JP7334675B2 (en) * | 2020-05-25 | 2023-08-29 | 株式会社デンソー | In-vehicle camera and vehicle control system |
CN112022326A (en) * | 2020-08-18 | 2020-12-04 | 上海市第十人民医院 | Spray freezing pipe with adjustable scope of action |
CN112263322A (en) * | 2020-09-29 | 2021-01-26 | 杭州睿笛生物科技有限公司 | Tumor ablation needle with blood coagulation function |
US20230066333A1 (en) * | 2021-08-24 | 2023-03-02 | Medtronic Holding Company Sàrl | Cooled bipolar radio-frequency ablation probe |
Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5456682A (en) * | 1991-11-08 | 1995-10-10 | Ep Technologies, Inc. | Electrode and associated systems using thermally insulated temperature sensing elements |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5728143A (en) * | 1995-08-15 | 1998-03-17 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5891094A (en) * | 1995-09-07 | 1999-04-06 | Innerdyne, Inc. | System for direct heating of fluid solution in a hollow body organ and methods |
US5954719A (en) * | 1996-12-11 | 1999-09-21 | Irvine Biomedical, Inc. | System for operating a RF ablation generator |
US6045549A (en) * | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
US6208881B1 (en) * | 1998-10-20 | 2001-03-27 | Micropure Medical, Inc. | Catheter with thin film electrodes and method for making same |
US20020123749A1 (en) * | 2001-03-01 | 2002-09-05 | Jain Mudit K. | Ablation catheter with transducer for providing one or more of pressure, temperature and fluid flow data for use in controlling ablation therapy |
US20030120271A1 (en) * | 2000-06-30 | 2003-06-26 | Scimed Life Systems, Inc. | Medical probe with reduced number of temperature sensor wires |
US20040260282A1 (en) * | 1995-08-15 | 2004-12-23 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with multiple sensor feedback |
US20060085054A1 (en) * | 2004-09-09 | 2006-04-20 | Zikorus Arthur W | Methods and apparatus for treatment of hollow anatomical structures |
US20060216275A1 (en) * | 2005-03-24 | 2006-09-28 | Celsion Corporation | Apparatus and method for pre-conditioning/fixation and treatment of disease with heat activation/release with thermoactivated drugs and gene products |
US20070027448A1 (en) * | 2005-07-27 | 2007-02-01 | Sauray Paul | Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation |
US20080161788A1 (en) * | 2006-12-28 | 2008-07-03 | Dando Jeremy D | Ablation Catheter With Sensor Array And Discrimination Circuit To Minimize Variation In Power Density |
US7416552B2 (en) * | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
US20080275440A1 (en) * | 2007-05-03 | 2008-11-06 | Medtronic, Inc. | Post-ablation verification of lesion size |
US20100030098A1 (en) * | 2008-03-18 | 2010-02-04 | Fojtik Shawn P | Large surface area temperature sensing device |
US20110160726A1 (en) * | 2009-12-30 | 2011-06-30 | Frank Ingle | Apparatus and methods for fluid cooled electrophysiology procedures |
US20110184403A1 (en) * | 2010-01-25 | 2011-07-28 | Vivant Medical, Inc. | System and Method for Monitoring Ablation Size |
US20110190756A1 (en) * | 2008-01-09 | 2011-08-04 | Mayo Foundation For Medical Education And Research | Mapping and ablation catheter system |
Family Cites Families (241)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1582135A (en) | 1976-07-14 | 1980-12-31 | Ferranti Ltd | Heaters |
US4424190A (en) | 1982-02-22 | 1984-01-03 | Cordis Dow Corp. | Rigid shell expansible blood reservoir, heater and hollow fiber membrane oxygenator assembly |
JPS6297971A (en) | 1985-10-21 | 1987-05-07 | 財団法人日本綿業技術・経済研究所 | Treatment agent for spinning cotton yarn |
JPS62211057A (en) | 1986-03-12 | 1987-09-17 | オリンパス光学工業株式会社 | Ultrasonic vibration treatment apparatus |
JPH01146539A (en) | 1987-12-03 | 1989-06-08 | Olympus Optical Co Ltd | Ultrasonic treatment apparatus |
US5549559A (en) | 1990-03-22 | 1996-08-27 | Argomed Ltd. | Thermal treatment apparatus |
JPH05506174A (en) | 1990-09-14 | 1993-09-16 | アメリカン・メディカル・システムズ・インコーポレーテッド | Combined hyperthermia and dilatation catheter |
US5190538A (en) | 1991-04-22 | 1993-03-02 | Trimedyne, Inc. | Method and apparatus for subjecting a body site to a movable beam of laterally directed laser radiation |
IT1251997B (en) | 1991-11-11 | 1995-05-27 | San Romanello Centro Fond | RADIANT DEVICE FOR HYPERTHERMIA |
JP3774477B2 (en) | 1992-02-10 | 2006-05-17 | アロカ株式会社 | Surgical device |
US5333603A (en) | 1992-02-25 | 1994-08-02 | Daniel Schuman | Endoscope with palm rest |
US5271413A (en) | 1992-07-22 | 1993-12-21 | Dalamagas Photios P | Method to sense the tissue for injection from a hypodermic needle |
WO1994010948A1 (en) * | 1992-11-12 | 1994-05-26 | Neuwirth Robert S | Heated balloon medical apparatus |
US5437673A (en) | 1993-02-04 | 1995-08-01 | Cryomedical Sciences, Inc. | Closed circulation tissue warming apparatus and method of using the same in prostate surgery |
US6033383A (en) | 1996-12-19 | 2000-03-07 | Ginsburg; Robert | Temperature regulating catheter and methods |
US5336222A (en) | 1993-03-29 | 1994-08-09 | Boston Scientific Corporation | Integrated catheter for diverse in situ tissue therapy |
US5403311A (en) | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5431649A (en) | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5449380A (en) | 1993-09-17 | 1995-09-12 | Origin Medsystems, Inc. | Apparatus and method for organ ablation |
US5536267A (en) * | 1993-11-08 | 1996-07-16 | Zomed International | Multiple electrode ablation apparatus |
US6071280A (en) * | 1993-11-08 | 2000-06-06 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus |
US6641580B1 (en) | 1993-11-08 | 2003-11-04 | Rita Medical Systems, Inc. | Infusion array ablation apparatus |
US5458597A (en) | 1993-11-08 | 1995-10-17 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5462521A (en) * | 1993-12-21 | 1995-10-31 | Angeion Corporation | Fluid cooled and perfused tip for a catheter |
US5409487A (en) | 1994-01-28 | 1995-04-25 | Yab Revo-Tech Inc. | Auxiliary tubing probe |
US5573510A (en) | 1994-02-28 | 1996-11-12 | Isaacson; Dennis R. | Safety intravenous catheter assembly with automatically retractable needle |
US5437629A (en) | 1994-04-14 | 1995-08-01 | Bei Medical Systems | Fluid delivery system for hysteroscopic endometrial ablation |
US20050187599A1 (en) | 1994-05-06 | 2005-08-25 | Hugh Sharkey | Method and apparatus for controlled contraction of soft tissue |
US5843021A (en) | 1994-05-09 | 1998-12-01 | Somnus Medical Technologies, Inc. | Cell necrosis apparatus |
US6024743A (en) | 1994-06-24 | 2000-02-15 | Edwards; Stuart D. | Method and apparatus for selective treatment of the uterus |
US5735846A (en) * | 1994-06-27 | 1998-04-07 | Ep Technologies, Inc. | Systems and methods for ablating body tissue using predicted maximum tissue temperature |
US5545195A (en) | 1994-08-01 | 1996-08-13 | Boston Scientific Corporation | Interstitial heating of tissue |
US5609151A (en) | 1994-09-08 | 1997-03-11 | Medtronic, Inc. | Method for R-F ablation |
CN1052170C (en) * | 1994-09-24 | 2000-05-10 | 华夏海南开发建设经营公司 | Purifying catalyst for gas exhausted from internal combustion engine |
US6678552B2 (en) | 1994-10-24 | 2004-01-13 | Transscan Medical Ltd. | Tissue characterization based on impedance images and on impedance measurements |
US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
US6030379A (en) | 1995-05-01 | 2000-02-29 | Ep Technologies, Inc. | Systems and methods for seeking sub-surface temperature conditions during tissue ablation |
SE505332C2 (en) * | 1995-05-18 | 1997-08-11 | Lund Instr Ab | Device for heat treatment of body tissue |
US5697949A (en) | 1995-05-18 | 1997-12-16 | Symbiosis Corporation | Small diameter endoscopic instruments |
US6772012B2 (en) | 1995-06-07 | 2004-08-03 | Arthrocare Corporation | Methods for electrosurgical treatment of spinal tissue |
US20050004634A1 (en) | 1995-06-07 | 2005-01-06 | Arthrocare Corporation | Methods for electrosurgical treatment of spinal tissue |
US7179255B2 (en) | 1995-06-07 | 2007-02-20 | Arthrocare Corporation | Methods for targeted electrosurgery on contained herniated discs |
WO2003024506A2 (en) | 2001-09-14 | 2003-03-27 | Arthrocare Corporation | Methods and apparatus for treating intervertebral discs |
EP0771176B2 (en) | 1995-06-23 | 2006-01-04 | Gyrus Medical Limited | An electrosurgical instrument |
US6235023B1 (en) | 1995-08-15 | 2001-05-22 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US6669685B1 (en) * | 1997-11-06 | 2003-12-30 | Biolase Technology, Inc. | Tissue remover and method |
US5653692A (en) | 1995-09-07 | 1997-08-05 | Innerdyne Medical, Inc. | Method and system for direct heating of fluid solution in a hollow body organ |
US6283951B1 (en) * | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
US6090106A (en) | 1996-01-09 | 2000-07-18 | Gyrus Medical Limited | Electrosurgical instrument |
US6475213B1 (en) | 1996-01-19 | 2002-11-05 | Ep Technologies, Inc. | Method of ablating body tissue |
US5800482A (en) | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
US6032077A (en) | 1996-03-06 | 2000-02-29 | Cardiac Pathways Corporation | Ablation catheter with electrical coupling via foam drenched with a conductive fluid |
US6419673B1 (en) | 1996-05-06 | 2002-07-16 | Stuart Edwards | Ablation of rectal and other internal body structures |
US6565561B1 (en) | 1996-06-20 | 2003-05-20 | Cyrus Medical Limited | Electrosurgical instrument |
US6620155B2 (en) | 1996-07-16 | 2003-09-16 | Arthrocare Corp. | System and methods for electrosurgical tissue contraction within the spine |
US6468274B1 (en) | 1996-07-16 | 2002-10-22 | Arthrocare Corporation | Systems and methods for treating spinal pain |
US5891134A (en) | 1996-09-24 | 1999-04-06 | Goble; Colin | System and method for applying thermal energy to tissue |
US5827269A (en) | 1996-12-31 | 1998-10-27 | Gynecare, Inc. | Heated balloon having a reciprocating fluid agitator |
US5797848A (en) * | 1997-01-31 | 1998-08-25 | Acuson Corporation | Ultrasonic transducer assembly with improved electrical interface |
US6411852B1 (en) | 1997-04-07 | 2002-06-25 | Broncus Technologies, Inc. | Modification of airways by application of energy |
US6272370B1 (en) | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
US6139570A (en) | 1997-05-19 | 2000-10-31 | Gynelab Products, Inc. | Disposable bladder for intrauterine use |
US6997925B2 (en) | 1997-07-08 | 2006-02-14 | Atrionx, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6139571A (en) | 1997-07-09 | 2000-10-31 | Fuller Research Corporation | Heated fluid surgical instrument |
US6080151A (en) | 1997-07-21 | 2000-06-27 | Daig Corporation | Ablation catheter |
US6056747A (en) | 1997-08-04 | 2000-05-02 | Gynecare, Inc. | Apparatus and method for treatment of body tissues |
US6176857B1 (en) * | 1997-10-22 | 2001-01-23 | Oratec Interventions, Inc. | Method and apparatus for applying thermal energy to tissue asymmetrically |
WO1999022656A1 (en) | 1997-10-30 | 1999-05-14 | Sonique Surgical Systems, Inc. | Laser-assisted liposuction method and apparatus |
JPH11178787A (en) | 1997-12-18 | 1999-07-06 | Olympus Optical Co Ltd | Endoscope system |
EP1042029B1 (en) * | 1997-12-22 | 2015-09-16 | Celgard, LLC | Device for removal of gas bubbles and dissolved gasses in liquid |
US7001378B2 (en) | 1998-03-31 | 2006-02-21 | Innercool Therapies, Inc. | Method and device for performing cooling or cryo-therapies, for, e.g., angioplasty with reduced restenosis or pulmonary vein cell necrosis to inhibit atrial fibrillation employing tissue protection |
US6337994B1 (en) | 1998-04-30 | 2002-01-08 | Johns Hopkins University | Surgical needle probe for electrical impedance measurements |
US6540725B1 (en) | 1998-06-04 | 2003-04-01 | Biosense Webster, Inc. | Injection catheter with controllably extendable injection needle |
US6494902B2 (en) | 1998-07-07 | 2002-12-17 | Medtronic, Inc. | Method for creating a virtual electrode for the ablation of tissue and for selected protection of tissue during an ablation |
US6238393B1 (en) | 1998-07-07 | 2001-05-29 | Medtronic, Inc. | Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue |
US6315777B1 (en) | 1998-07-07 | 2001-11-13 | Medtronic, Inc. | Method and apparatus for creating a virtual electrode used for the ablation of tissue |
US6112123A (en) | 1998-07-28 | 2000-08-29 | Endonetics, Inc. | Device and method for ablation of tissue |
US6450990B1 (en) | 1998-08-13 | 2002-09-17 | Alsius Corporation | Catheter with multiple heating/cooling fibers employing fiber spreading features |
AU5365599A (en) | 1998-08-14 | 2000-03-06 | K.U. Leuven Research & Development | Cooled-wet electrode |
US6328735B1 (en) * | 1998-10-30 | 2001-12-11 | E.P., Limited | Thermal ablation system |
US6210406B1 (en) | 1998-12-03 | 2001-04-03 | Cordis Webster, Inc. | Split tip electrode catheter and signal processing RF ablation system |
SE9804388D0 (en) | 1998-12-17 | 1998-12-17 | Wallsten Medical Sa | Device and method of medical treatment |
US6233490B1 (en) | 1999-02-09 | 2001-05-15 | Kai Technologies, Inc. | Microwave antennas for medical hyperthermia, thermotherapy and diagnosis |
ATE365058T1 (en) * | 1999-03-02 | 2007-07-15 | Atrionix Inc | ATRIAL ABLATION DEVICE WITH BALLOON AND SENSOR |
US6203507B1 (en) | 1999-03-03 | 2001-03-20 | Cordis Webster, Inc. | Deflectable catheter with ergonomic handle |
US6358273B1 (en) | 1999-04-09 | 2002-03-19 | Oratec Inventions, Inc. | Soft tissue heating apparatus with independent, cooperative heating sources |
AU5142900A (en) * | 1999-05-21 | 2000-12-12 | Arthrocare Corporation | Systems and methods for electrosurgical treatment of intervertebral discs |
EP1200213B1 (en) | 1999-07-29 | 2003-03-05 | Hatebur Umformmaschinen AG | Device for producing a lifting and lowering movement |
US7815590B2 (en) | 1999-08-05 | 2010-10-19 | Broncus Technologies, Inc. | Devices for maintaining patency of surgically created channels in tissue |
US6463332B1 (en) | 1999-09-17 | 2002-10-08 | Core Medical, Inc. | Method and system for pericardial enhancement |
US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
US6443947B1 (en) | 2000-03-01 | 2002-09-03 | Alexei Marko | Device for thermal ablation of a cavity |
US20040220559A1 (en) * | 2000-03-01 | 2004-11-04 | Kramer Hans W. | Preparation of working fluid for use in cryotherapies |
ES2643763T3 (en) | 2000-03-06 | 2017-11-24 | Salient Surgical Technologies, Inc. | Fluid supply system and controller for electrosurgical devices |
WO2001074251A2 (en) | 2000-03-31 | 2001-10-11 | Rita Medical Systems Inc. | Tissue biopsy and treatment apparatus and method |
FR2807827B1 (en) | 2000-04-12 | 2002-07-05 | Technomed Medical Systems | FLUID HANDLING SYSTEM FOR THERAPY APPARATUS |
US20020107514A1 (en) | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
US6405067B1 (en) | 2000-07-07 | 2002-06-11 | Biosense Webster, Inc. | Catheter with tip electrode having a recessed ring electrode mounted thereon |
US6477396B1 (en) | 2000-07-07 | 2002-11-05 | Biosense Webster, Inc. | Mapping and ablation catheter |
US20020068885A1 (en) * | 2000-07-13 | 2002-06-06 | Harhen Edward Paul | Energy application with inflatable annular lens |
WO2002032335A1 (en) | 2000-07-25 | 2002-04-25 | Rita Medical Systems Inc. | Apparatus for detecting and treating tumors using localized impedance measurement |
US6855154B2 (en) | 2000-08-11 | 2005-02-15 | University Of Louisville Research Foundation, Inc. | Endovascular aneurysm treatment device and method |
CN1246052C (en) | 2000-09-06 | 2006-03-22 | 辅助呼吸产品公司 | Heating system of intravenous fluid infusion |
US6564096B2 (en) | 2001-02-28 | 2003-05-13 | Robert A. Mest | Method and system for treatment of tachycardia and fibrillation |
US6418968B1 (en) | 2001-04-20 | 2002-07-16 | Nanostream, Inc. | Porous microfluidic valves |
EP1385439A1 (en) | 2001-05-10 | 2004-02-04 | Rita Medical Systems, Inc. | Rf tissue ablation apparatus and method |
US6752802B1 (en) | 2001-07-09 | 2004-06-22 | Ethicon, Inc. | Method and apparatus for the prevention of endometrial hyperplasis and uterine cancer |
AU2002326548A1 (en) * | 2001-08-17 | 2003-04-14 | Innercool Therapies, Inc. | Preparation of working fluid for use in cryotherapies |
AU2002336575A1 (en) * | 2001-09-14 | 2003-04-01 | Arthrocare Corporation | Electrosurgical apparatus and methods for tissue treatment and removal |
GB2379878B (en) * | 2001-09-21 | 2004-11-10 | Gyrus Medical Ltd | Electrosurgical system and method |
US6814730B2 (en) | 2001-10-09 | 2004-11-09 | Hong Li | Balloon catheters for non-continuous lesions |
US7070597B2 (en) | 2001-10-18 | 2006-07-04 | Surgrx, Inc. | Electrosurgical working end for controlled energy delivery |
US6603997B2 (en) | 2001-11-02 | 2003-08-05 | Michael C. Doody | Probe penetration detector and method of operation |
US20050267552A1 (en) | 2004-05-26 | 2005-12-01 | Baylis Medical Company Inc. | Electrosurgical device |
US7187960B2 (en) | 2002-04-22 | 2007-03-06 | Marcio Marc Abreu | Apparatus and method for measuring biologic parameters |
JP4394864B2 (en) | 2002-05-07 | 2010-01-06 | テルモ株式会社 | Metal tubular body and manufacturing method thereof |
US7294143B2 (en) | 2002-05-16 | 2007-11-13 | Medtronic, Inc. | Device and method for ablation of cardiac tissue |
IL149706A0 (en) * | 2002-05-16 | 2002-11-10 | Dolopaz Technologies Ltd | Multipurpose fluid jet surgical device |
EP3175880B1 (en) | 2002-06-20 | 2018-08-15 | Becton, Dickinson and Company | Apparatus for shielding the tip of a catheter introducer needle |
JP2004024331A (en) | 2002-06-21 | 2004-01-29 | Vayu:Kk | Catheter |
US20040006336A1 (en) | 2002-07-02 | 2004-01-08 | Scimed Life Systems, Inc. | Apparatus and method for RF ablation into conductive fluid-infused tissue |
US20040116922A1 (en) * | 2002-09-05 | 2004-06-17 | Arthrocare Corporation | Methods and apparatus for treating intervertebral discs |
WO2004039273A2 (en) * | 2002-10-31 | 2004-05-13 | C.R. Bard, Inc. | Electrophysiology catheter with biased tip |
AU2002952663A0 (en) | 2002-11-14 | 2002-11-28 | Western Sydney Area Health Service | An intramural needle-tipped surgical device |
AT507045B1 (en) | 2002-11-29 | 2010-04-15 | Cochlear Ltd | IMPLANTABLE, TISSUE-STIMULATING DEVICE |
US6972014B2 (en) | 2003-01-04 | 2005-12-06 | Endocare, Inc. | Open system heat exchange catheters and methods of use |
JP2004275594A (en) | 2003-03-18 | 2004-10-07 | Terumo Corp | Catheter with needle projection adjusting mechanism |
US7025768B2 (en) | 2003-05-06 | 2006-04-11 | Boston Scientific Scimed, Inc. | Systems and methods for ablation of tissue |
US20060129091A1 (en) | 2004-12-10 | 2006-06-15 | Possis Medical, Inc. | Enhanced cross stream mechanical thrombectomy catheter with backloading manifold |
US7235070B2 (en) | 2003-07-02 | 2007-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation fluid manifold for ablation catheter |
US7311703B2 (en) * | 2003-07-18 | 2007-12-25 | Vivant Medical, Inc. | Devices and methods for cooling microwave antennas |
US7104989B2 (en) | 2003-09-05 | 2006-09-12 | Medtronic, Inc. | RF ablation catheter including a virtual electrode assembly |
US20050059963A1 (en) | 2003-09-12 | 2005-03-17 | Scimed Life Systems, Inc. | Systems and method for creating transmural lesions |
US20050080410A1 (en) | 2003-10-14 | 2005-04-14 | Scimed Life Systems, Inc. | Liquid infusion apparatus for radiofrequency tissue ablation |
US7179256B2 (en) | 2003-10-24 | 2007-02-20 | Biosense Webster, Inc. | Catheter with ablation needle and mapping assembly |
US7155270B2 (en) | 2003-10-24 | 2006-12-26 | Biosense Webster, Inc. | Catheter with multi-spine mapping assembly |
US7207989B2 (en) | 2003-10-27 | 2007-04-24 | Biosense Webster, Inc. | Method for ablating with needle electrode |
NL1024658C2 (en) | 2003-10-29 | 2005-05-02 | Univ Medisch Centrum Utrecht | Catheter and method, in particular for ablation and the like. |
US7282051B2 (en) | 2004-02-04 | 2007-10-16 | Boston Scientific Scimed, Inc. | Ablation probe for delivering fluid through porous structure |
US20050192652A1 (en) | 2004-02-26 | 2005-09-01 | Iulian Cioanta | Thermal treatment systems with enhanced tissue penetration depth using adjustable treatment pressures and related methods |
WO2005089663A1 (en) | 2004-03-05 | 2005-09-29 | Medelec-Minimeca S.A. | Saline-enhanced catheter for radiofrequency tumor ablation |
CN1942145A (en) * | 2004-04-19 | 2007-04-04 | 普罗里森姆股份有限公司 | Ablation devices with sensor structures |
US20050245923A1 (en) * | 2004-04-29 | 2005-11-03 | Medtronic, Inc. | Biopolar virtual electrode for transurethral needle ablation |
US7244254B2 (en) | 2004-04-29 | 2007-07-17 | Micrablate | Air-core microwave ablation antennas |
US7101369B2 (en) | 2004-04-29 | 2006-09-05 | Wisconsin Alumni Research Foundation | Triaxial antenna for microwave tissue ablation |
US9061120B2 (en) | 2004-08-05 | 2015-06-23 | Oscor Inc. | Catheter control mechanism and steerable catheter |
US7412273B2 (en) | 2004-11-15 | 2008-08-12 | Biosense Webster, Inc. | Soft linear mapping catheter with stabilizing tip |
MX2007005890A (en) * | 2004-11-15 | 2007-10-18 | Johnson & Johnson | Catheter with multiple microfabricated temperature sensors. |
US20060118127A1 (en) | 2004-12-06 | 2006-06-08 | Chinn Douglas O | Tissue protective system and method for thermoablative therapies |
AU2005314712A1 (en) * | 2004-12-09 | 2006-06-15 | Palomar Medical Technologies, Inc. | Oral appliance with heat transfer mechanism |
US7666166B1 (en) | 2004-12-27 | 2010-02-23 | Blivic, Llc | Bloodless intravenous integrated catheter |
KR100640283B1 (en) * | 2004-12-28 | 2006-11-01 | 최정숙 | Electrode for radiofrequency tissue ablation |
GB0504988D0 (en) | 2005-03-10 | 2005-04-20 | Emcision Ltd | Device and method for the treatment of diseased tissue such as tumors |
US7942873B2 (en) | 2005-03-25 | 2011-05-17 | Angiodynamics, Inc. | Cavity ablation apparatus and method |
WO2006103951A1 (en) | 2005-03-29 | 2006-10-05 | Terumo Kabushiki Kaisha | Liquid-supplying tube for medical use provided with deaeration module, assembly of medical machines using the liquid-supplying tube for medical use, deaeration module and method of supplying liquid |
US7799019B2 (en) | 2005-05-10 | 2010-09-21 | Vivant Medical, Inc. | Reinforced high strength microwave antenna |
US8128621B2 (en) | 2005-05-16 | 2012-03-06 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Irrigated ablation electrode assembly and method for control of temperature |
US8333776B2 (en) | 2005-05-20 | 2012-12-18 | Neotract, Inc. | Anchor delivery system |
US7621890B2 (en) | 2005-06-09 | 2009-11-24 | Endocare, Inc. | Heat exchange catheter with multi-lumen tube having a fluid return passageway |
US8123693B2 (en) | 2005-06-20 | 2012-02-28 | Conceptus, Inc. | Methods and devices for determining lumen occlusion |
US7819868B2 (en) | 2005-06-21 | 2010-10-26 | St. Jude Medical, Atrial Fibrilation Division, Inc. | Ablation catheter with fluid distribution structures |
US8353906B2 (en) * | 2005-08-01 | 2013-01-15 | Ceramatec, Inc. | Electrochemical probe and method for in situ treatment of a tissue |
US7766906B2 (en) | 2005-08-19 | 2010-08-03 | Boston Scientific Scimed, Inc. | Occlusion apparatus |
US20070078453A1 (en) * | 2005-10-04 | 2007-04-05 | Johnson Kristin D | System and method for performing cardiac ablation |
US8182444B2 (en) | 2005-11-04 | 2012-05-22 | Medrad, Inc. | Delivery of agents such as cells to tissue |
BRPI0619725A2 (en) | 2005-12-06 | 2011-10-11 | St Jude Medical Atrial Fibrill | tissue ablation electrode junction evaluation |
US8449535B2 (en) | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US20070167775A1 (en) | 2005-12-15 | 2007-07-19 | Galil Medical Ltd. | Method and apparatus for protecting the rectal wall during cryoablation |
CA2636505A1 (en) | 2006-01-09 | 2007-07-19 | Biospiral Ltd. | System and method for thermally treating tissues |
CN2885157Y (en) * | 2006-03-23 | 2007-04-04 | 迈德医疗科技(上海)有限公司 | Perfuseable probe electrode |
US9814519B2 (en) | 2006-04-20 | 2017-11-14 | Boston Scientific Scimed, Inc. | Ablation probe with ribbed insulated sheath |
US8486127B2 (en) | 2006-05-24 | 2013-07-16 | Kambiz Dowlatshahi | High temperature thermal therapy of breast cancer |
EP2020943B1 (en) | 2006-05-30 | 2015-07-08 | ArthroCare Corporation | Hard tissue ablation system |
US7662152B2 (en) | 2006-06-13 | 2010-02-16 | Biosense Webster, Inc. | Catheter with multi port tip for optical lesion evaluation |
US7559905B2 (en) | 2006-09-21 | 2009-07-14 | Focus Surgery, Inc. | HIFU probe for treating tissue with in-line degassing of fluid |
WO2008045925A2 (en) | 2006-10-10 | 2008-04-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation electrode assembly with insulated distal outlet |
US8728073B2 (en) | 2006-10-10 | 2014-05-20 | Biosense Webster, Inc. | Multi-region staged inflation balloon |
WO2008045877A2 (en) | 2006-10-10 | 2008-04-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode tip and ablation system |
CN100574719C (en) | 2006-12-26 | 2009-12-30 | 上海导向医疗系统有限公司 | Gas throttling cooling type radio frequency ablation electrode |
US7951143B2 (en) | 2006-12-28 | 2011-05-31 | St. Jude Medical, Artial Fibrillation Divsion, Inc. | Cooled ablation catheter with reciprocating flow |
US8460285B2 (en) | 2006-12-29 | 2013-06-11 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter electrode having multiple thermal sensors and method of use |
US8764742B2 (en) | 2007-04-04 | 2014-07-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Irrigated catheter |
US9314298B2 (en) | 2007-04-17 | 2016-04-19 | St. Jude Medical, Atrial Fibrillation Divisions, Inc. | Vacuum-stabilized ablation system |
US8579886B2 (en) | 2007-05-01 | 2013-11-12 | Covidien Lp | Accordion style cable stand-off |
US20080281200A1 (en) | 2007-05-10 | 2008-11-13 | Misonix, Incorporated | Elevated coupling liquid temperature during HIFU treatment method and hardware |
CN101801445B (en) | 2007-08-14 | 2013-04-17 | 弗雷德哈钦森癌症研究中心 | Needle array assembly for delivering therapeutic agents |
JP2010540028A (en) | 2007-09-20 | 2010-12-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Hand-held thermal ablation device |
US20090088785A1 (en) * | 2007-09-28 | 2009-04-02 | Shinya Masuda | Surgical operating apparatus |
US9023030B2 (en) | 2007-10-09 | 2015-05-05 | Boston Scientific Scimed, Inc. | Cooled ablation catheter devices and methods of use |
CN101411645A (en) * | 2007-10-19 | 2009-04-22 | 上海导向医疗系统有限公司 | The uniform radio-frequency ablation electrode of surface temperature |
US8535306B2 (en) | 2007-11-05 | 2013-09-17 | Angiodynamics, Inc. | Ablation devices and methods of using the same |
US8439907B2 (en) | 2007-11-07 | 2013-05-14 | Mirabilis Medica Inc. | Hemostatic tissue tunnel generator for inserting treatment apparatus into tissue of a patient |
US8128620B2 (en) | 2007-11-13 | 2012-03-06 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Irrigated ablation electrode having proximal direction flow |
US20090125014A1 (en) * | 2007-11-14 | 2009-05-14 | Bouthillier Robert J | Thermal Ablation System |
US8273082B2 (en) | 2007-12-21 | 2012-09-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Irrigated ablation catheter assembly having a flow member to create parallel external flow |
US8444579B2 (en) * | 2007-12-21 | 2013-05-21 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System for delivering acoustic energy in connection with therapeutic ultrasound systems and catheters |
US8333762B2 (en) | 2007-12-28 | 2012-12-18 | Biosense Webster, Inc. | Irrigated catheter with improved irrigation flow |
US8251993B2 (en) | 2008-01-25 | 2012-08-28 | Edward Luttich | Method and device for less invasive surgical procedures on animals |
US20090254083A1 (en) | 2008-03-10 | 2009-10-08 | Hansen Medical, Inc. | Robotic ablation catheter |
US20100004595A1 (en) | 2008-07-01 | 2010-01-07 | Ethicon, Inc. | Balloon catheter systems for treating uterine disorders having fluid line de-gassing assemblies and methods therefor |
JP2010046200A (en) | 2008-08-20 | 2010-03-04 | Fujinon Corp | High frequency treatment tool |
US8439905B2 (en) * | 2008-09-19 | 2013-05-14 | Endocare, Inc. | Nucleation enhanced surface modification to support physical vapor deposition to create a vacuum |
EP2364128A4 (en) | 2008-09-30 | 2013-07-24 | Dfine Inc | System for use in treatment of vertebral fractures |
US8758349B2 (en) | 2008-10-13 | 2014-06-24 | Dfine, Inc. | Systems for treating a vertebral body |
US8512328B2 (en) | 2008-10-13 | 2013-08-20 | Covidien Lp | Antenna assemblies for medical applications |
US9757189B2 (en) * | 2008-12-03 | 2017-09-12 | Biosense Webster, Inc. | Prevention of kinks in catheter irrigation tubes |
US20100185172A1 (en) | 2009-01-20 | 2010-07-22 | Mariel Fabro | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods |
WO2010151619A2 (en) * | 2009-06-24 | 2010-12-29 | Optogen Medical Llc | Devices, systems and methods for treatment of soft tissue |
CN201642316U (en) | 2009-11-18 | 2010-11-24 | 南京康友微波能应用研究所 | Microwave ablation needle and microwave ablation therapeutic instrument employing same |
US10058336B2 (en) | 2010-04-08 | 2018-08-28 | Dfine, Inc. | System for use in treatment of vertebral fractures |
US9943363B2 (en) | 2010-04-28 | 2018-04-17 | Biosense Webster, Inc. | Irrigated ablation catheter with improved fluid flow |
US9510894B2 (en) | 2010-04-28 | 2016-12-06 | Biosense Webster (Israel) Ltd. | Irrigated ablation catheter having irrigation ports with reduced hydraulic resistance |
BR112012027708B1 (en) | 2010-04-29 | 2021-03-09 | Dfine, Inc | medical device for ablation of tissue within a patient's bone |
US8696659B2 (en) | 2010-04-30 | 2014-04-15 | Arthrocare Corporation | Electrosurgical system and method having enhanced temperature measurement |
WO2011141800A1 (en) | 2010-05-10 | 2011-11-17 | Endosense S.A. | Irrigated finned ablation head |
US7938822B1 (en) | 2010-05-12 | 2011-05-10 | Icecure Medical Ltd. | Heating and cooling of cryosurgical instrument using a single cryogen |
US9649116B2 (en) | 2010-11-22 | 2017-05-16 | Dfine, Inc. | System for use in treatment of vertebral fractures |
WO2012071058A1 (en) | 2010-11-23 | 2012-05-31 | William Joseph Drasler | Venous heated ablation catheter |
CN101999931B (en) * | 2010-12-10 | 2012-11-14 | 上海导向医疗系统有限公司 | Cryoablation probe shell covered by expandable hydrogel and preparation method thereof |
US9855094B2 (en) | 2010-12-28 | 2018-01-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multi-rate fluid flow and variable power delivery for ablation electrode assemblies used in catheter ablation procedures |
EP3834757B1 (en) | 2011-01-19 | 2022-03-09 | Fractyl Health, Inc. | Devices for the treatment of the small intestine |
US20120253188A1 (en) | 2011-03-29 | 2012-10-04 | University Of Rochester | Reducing risk of complications associated with tissue ablation |
EP3785653A1 (en) | 2011-04-12 | 2021-03-03 | Thermedical, Inc. | Devices for remote temperature monitoring in fluid enhanced ablation therapy |
US20120310230A1 (en) | 2011-06-01 | 2012-12-06 | Angiodynamics, Inc. | Coaxial dual function probe and method of use |
US9314588B2 (en) | 2011-10-28 | 2016-04-19 | Medtronic Cryocath Lp | Systems and methods for variable injection flow |
BR112014024028B1 (en) | 2012-03-27 | 2022-05-31 | Dfine, Inc | Medical device for creating heated tissue regions using temperature to monitor a desired profile of the regions |
WO2013159066A1 (en) | 2012-04-19 | 2013-10-24 | Fractyl Laboratories, Inc. | Tissue expansion devices, system and methods |
US8700133B2 (en) | 2012-06-18 | 2014-04-15 | Smart Iv Llc | Apparatus and method for monitoring catheter insertion |
US10022176B2 (en) | 2012-08-15 | 2018-07-17 | Thermedical, Inc. | Low profile fluid enhanced ablation therapy devices and methods |
WO2014089373A1 (en) | 2012-12-05 | 2014-06-12 | University Of Rochester | Catheter with integrated transeptal puncture needle |
WO2014151822A2 (en) | 2013-03-15 | 2014-09-25 | Boston Scientific Scimed, Inc. | Open irrigated ablation catheter |
US9033972B2 (en) | 2013-03-15 | 2015-05-19 | Thermedical, Inc. | Methods and devices for fluid enhanced microwave ablation therapy |
US9610396B2 (en) | 2013-03-15 | 2017-04-04 | Thermedical, Inc. | Systems and methods for visualizing fluid enhanced ablation therapy |
AU2015236341B2 (en) | 2014-03-24 | 2020-03-05 | Old Dominion University Research Foundation | Expandable catheter devices electrode array |
US9848943B2 (en) | 2014-04-18 | 2017-12-26 | Biosense Webster (Israel) Ltd. | Ablation catheter with dedicated fluid paths and needle centering insert |
EP3220843B1 (en) | 2014-11-19 | 2020-01-01 | EPiX Therapeutics, Inc. | Ablation devices and methods of using a high-resolution electrode assembly |
US10463425B2 (en) | 2015-05-04 | 2019-11-05 | Biosense Webster (Israel) Ltd. | RF ablation with acoustic feedback |
US9844664B2 (en) | 2015-10-12 | 2017-12-19 | Medtronic, Inc. | Interventional medical systems, catheters, and subassemblies |
US9743984B1 (en) | 2016-08-11 | 2017-08-29 | Thermedical, Inc. | Devices and methods for delivering fluid to tissue during ablation therapy |
US11083871B2 (en) | 2018-05-03 | 2021-08-10 | Thermedical, Inc. | Selectively deployable catheter ablation devices |
US11918277B2 (en) | 2018-07-16 | 2024-03-05 | Thermedical, Inc. | Inferred maximum temperature monitoring for irrigated ablation therapy |
-
2012
- 2012-04-12 EP EP20184347.1A patent/EP3785653A1/en not_active Withdrawn
- 2012-04-12 US US13/445,373 patent/US9445861B2/en active Active
- 2012-04-12 BR BR112013026260A patent/BR112013026260A2/en not_active IP Right Cessation
- 2012-04-12 WO PCT/US2012/033203 patent/WO2012142211A1/en active Application Filing
- 2012-04-12 JP JP2014505263A patent/JP6189826B2/en active Active
- 2012-04-12 AU AU2012242851A patent/AU2012242851A1/en not_active Abandoned
- 2012-04-12 US US13/445,036 patent/US9138287B2/en active Active
- 2012-04-12 EP EP12770631.5A patent/EP2696786B1/en active Active
- 2012-04-12 CN CN201280028620.5A patent/CN103619276B/en not_active Expired - Fee Related
- 2012-04-12 WO PCT/US2012/033327 patent/WO2012142291A1/en unknown
- 2012-04-12 CN CN201711019074.XA patent/CN107753098B/en not_active Expired - Fee Related
- 2012-04-12 ES ES12770631T patent/ES2817851T3/en active Active
- 2012-04-12 ES ES12771601T patent/ES2892774T3/en active Active
- 2012-04-12 AU AU2012242845A patent/AU2012242845A1/en not_active Abandoned
- 2012-04-12 EP EP12771601.7A patent/EP2696788B1/en active Active
- 2012-04-12 ES ES12770537T patent/ES2864589T3/en active Active
- 2012-04-12 CN CN202010767280.4A patent/CN112057159A/en active Pending
- 2012-04-12 KR KR1020207013609A patent/KR102283571B1/en active IP Right Grant
- 2012-04-12 JP JP2014505282A patent/JP6235458B2/en active Active
- 2012-04-12 CN CN201610676584.3A patent/CN106420040B/en active Active
- 2012-04-12 US US13/445,034 patent/US20120277737A1/en not_active Abandoned
- 2012-04-12 AU AU2012242744A patent/AU2012242744B2/en not_active Ceased
- 2012-04-12 CN CN201280028611.6A patent/CN103764055B/en active Active
- 2012-04-12 WO PCT/US2012/033216 patent/WO2012142219A1/en active Application Filing
- 2012-04-12 CN CN201611215279.0A patent/CN106901830B/en active Active
- 2012-04-12 EP EP12771331.1A patent/EP2696787B1/en active Active
- 2012-04-12 JP JP2014505285A patent/JP6297971B2/en active Active
- 2012-04-12 BR BR112013026029A patent/BR112013026029A2/en not_active IP Right Cessation
- 2012-04-12 KR KR1020197038391A patent/KR102212427B1/en active IP Right Grant
- 2012-04-12 KR KR1020137030026A patent/KR102123083B1/en active IP Right Grant
- 2012-04-12 AU AU2012242853A patent/AU2012242853B2/en active Active
- 2012-04-12 EP EP19151775.4A patent/EP3498208A1/en active Pending
- 2012-04-12 US US13/445,365 patent/US8702697B2/en active Active
- 2012-04-12 BR BR112013026126A patent/BR112013026126A2/en not_active IP Right Cessation
- 2012-04-12 WO PCT/US2012/033213 patent/WO2012142217A1/en active Application Filing
- 2012-04-12 CN CN201280028609.9A patent/CN103596513B/en not_active Expired - Fee Related
- 2012-04-12 EP EP12770537.4A patent/EP2696789B1/en active Active
- 2012-04-12 CN CN201710537279.0A patent/CN107334529B/en active Active
- 2012-04-12 KR KR1020137030024A patent/KR20140022884A/en not_active Application Discontinuation
- 2012-04-12 KR KR1020217023589A patent/KR20210095738A/en not_active Application Discontinuation
- 2012-04-12 WO PCT/US2012/033332 patent/WO2012142296A1/en unknown
- 2012-04-12 AU AU2012242739A patent/AU2012242739A1/en not_active Abandoned
- 2012-04-12 US US13/445,040 patent/US8945121B2/en active Active
- 2012-04-12 EP EP12771876.5A patent/EP2696790B1/en active Active
- 2012-04-12 BR BR112013026016A patent/BR112013026016A2/en not_active IP Right Cessation
- 2012-04-12 KR KR1020137030022A patent/KR102061899B1/en active IP Right Grant
- 2012-04-12 JP JP2014505267A patent/JP6170037B2/en active Active
- 2012-04-12 BR BR112013026176A patent/BR112013026176A2/en not_active IP Right Cessation
- 2012-04-12 CN CN201280028621.XA patent/CN103764056B/en not_active Expired - Fee Related
- 2012-04-12 EP EP21191571.5A patent/EP3932347A1/en active Pending
- 2012-04-12 CN CN201280028612.0A patent/CN103619275B/en active Active
- 2012-04-12 KR KR1020137030025A patent/KR102061901B1/en active IP Right Grant
- 2012-04-12 KR KR1020197038383A patent/KR102168241B1/en active IP Right Grant
- 2012-04-12 ES ES12771876T patent/ES2864590T3/en active Active
- 2012-04-12 KR KR1020137030027A patent/KR102112356B1/en active IP Right Grant
- 2012-04-12 JP JP2014505266A patent/JP6297970B2/en active Active
-
2014
- 2014-03-10 US US14/202,425 patent/US9730748B2/en active Active
- 2014-11-07 US US14/536,212 patent/US9138288B2/en active Active
-
2015
- 2015-08-14 US US14/826,549 patent/US9877768B2/en active Active
- 2015-08-14 US US14/826,563 patent/US10307201B2/en active Active
-
2016
- 2016-08-18 US US15/240,693 patent/US9937000B2/en not_active Expired - Fee Related
- 2016-10-27 AU AU2016250432A patent/AU2016250432B2/en active Active
-
2017
- 2017-01-27 AU AU2017200549A patent/AU2017200549B2/en active Active
- 2017-03-06 US US15/450,806 patent/US10548654B2/en active Active
- 2017-06-29 JP JP2017127654A patent/JP6559186B2/en active Active
- 2017-07-31 US US15/663,914 patent/US10881443B2/en active Active
- 2017-08-03 JP JP2017151156A patent/JP6753561B2/en active Active
- 2017-10-26 JP JP2017207454A patent/JP2018030000A/en active Pending
-
2018
- 2018-01-03 US US15/861,359 patent/US20180140345A1/en not_active Abandoned
- 2018-02-22 JP JP2018029767A patent/JP6730341B2/en not_active Expired - Fee Related
- 2018-03-01 US US15/909,103 patent/US10448987B2/en active Active
-
2019
- 2019-04-02 US US16/373,104 patent/US11135000B2/en active Active
- 2019-07-16 JP JP2019131314A patent/JP6849747B2/en active Active
- 2019-08-16 JP JP2019149270A patent/JP2020014855A/en active Pending
- 2019-10-22 US US16/660,212 patent/US11871979B2/en active Active
- 2019-12-19 US US16/720,581 patent/US11583330B2/en active Active
- 2019-12-27 JP JP2019239690A patent/JP2020054873A/en active Pending
-
2021
- 2021-09-02 US US17/465,780 patent/US11950829B2/en active Active
- 2021-10-15 JP JP2021169803A patent/JP2022009186A/en active Pending
-
2023
- 2023-01-20 US US18/099,508 patent/US20230414267A1/en active Pending
- 2023-11-06 JP JP2023189133A patent/JP2024001360A/en active Pending
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5456682A (en) * | 1991-11-08 | 1995-10-10 | Ep Technologies, Inc. | Electrode and associated systems using thermally insulated temperature sensing elements |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
US5728143A (en) * | 1995-08-15 | 1998-03-17 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US20040260282A1 (en) * | 1995-08-15 | 2004-12-23 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with multiple sensor feedback |
US5891094A (en) * | 1995-09-07 | 1999-04-06 | Innerdyne, Inc. | System for direct heating of fluid solution in a hollow body organ and methods |
US5954719A (en) * | 1996-12-11 | 1999-09-21 | Irvine Biomedical, Inc. | System for operating a RF ablation generator |
US6045549A (en) * | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
US6208881B1 (en) * | 1998-10-20 | 2001-03-27 | Micropure Medical, Inc. | Catheter with thin film electrodes and method for making same |
US20030120271A1 (en) * | 2000-06-30 | 2003-06-26 | Scimed Life Systems, Inc. | Medical probe with reduced number of temperature sensor wires |
US20020123749A1 (en) * | 2001-03-01 | 2002-09-05 | Jain Mudit K. | Ablation catheter with transducer for providing one or more of pressure, temperature and fluid flow data for use in controlling ablation therapy |
US20060085054A1 (en) * | 2004-09-09 | 2006-04-20 | Zikorus Arthur W | Methods and apparatus for treatment of hollow anatomical structures |
US20060216275A1 (en) * | 2005-03-24 | 2006-09-28 | Celsion Corporation | Apparatus and method for pre-conditioning/fixation and treatment of disease with heat activation/release with thermoactivated drugs and gene products |
US20070027448A1 (en) * | 2005-07-27 | 2007-02-01 | Sauray Paul | Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation |
US7416552B2 (en) * | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
US20080161788A1 (en) * | 2006-12-28 | 2008-07-03 | Dando Jeremy D | Ablation Catheter With Sensor Array And Discrimination Circuit To Minimize Variation In Power Density |
US20080275440A1 (en) * | 2007-05-03 | 2008-11-06 | Medtronic, Inc. | Post-ablation verification of lesion size |
US20110190756A1 (en) * | 2008-01-09 | 2011-08-04 | Mayo Foundation For Medical Education And Research | Mapping and ablation catheter system |
US20100030098A1 (en) * | 2008-03-18 | 2010-02-04 | Fojtik Shawn P | Large surface area temperature sensing device |
US20110160726A1 (en) * | 2009-12-30 | 2011-06-30 | Frank Ingle | Apparatus and methods for fluid cooled electrophysiology procedures |
US20110184403A1 (en) * | 2010-01-25 | 2011-07-28 | Vivant Medical, Inc. | System and Method for Monitoring Ablation Size |
Cited By (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10182862B2 (en) | 2005-02-02 | 2019-01-22 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US11419668B2 (en) | 2005-02-02 | 2022-08-23 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US9987080B2 (en) | 2005-02-02 | 2018-06-05 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US9808310B2 (en) | 2005-02-02 | 2017-11-07 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US11950837B2 (en) | 2005-02-02 | 2024-04-09 | Gynesonics, Inc. | Method and device for uterine fibroid treatment |
US11259825B2 (en) | 2006-01-12 | 2022-03-01 | Gynesonics, Inc. | Devices and methods for treatment of tissue |
US11096760B2 (en) | 2007-10-12 | 2021-08-24 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
US11096761B2 (en) | 2007-10-12 | 2021-08-24 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
US11826207B2 (en) | 2007-10-12 | 2023-11-28 | Gynesonics, Inc | Methods and systems for controlled deployment of needles in tissue |
US11925512B2 (en) | 2007-10-12 | 2024-03-12 | Gynesonics, Inc. | Methods and systems for controlled deployment of needles in tissue |
US11564735B2 (en) | 2009-02-27 | 2023-01-31 | Gynesonics, Inc. | Needle and fine deployment mechanism |
US9277961B2 (en) | 2009-06-12 | 2016-03-08 | Advanced Cardiac Therapeutics, Inc. | Systems and methods of radiometrically determining a hot-spot temperature of tissue being treated |
US9730748B2 (en) | 2011-04-12 | 2017-08-15 | Thermedical, Inc. | Devices and methods for shaping therapy in fluid enhanced ablation |
US8702697B2 (en) | 2011-04-12 | 2014-04-22 | Thermedical, Inc. | Devices and methods for shaping therapy in fluid enhanced ablation |
US10881443B2 (en) | 2011-04-12 | 2021-01-05 | Thermedical, Inc. | Devices and methods for shaping therapy in fluid enhanced ablation |
US11950829B2 (en) | 2011-04-12 | 2024-04-09 | Thermedical, Inc. | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US9138287B2 (en) | 2011-04-12 | 2015-09-22 | Thermedical, Inc. | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US10548654B2 (en) | 2011-04-12 | 2020-02-04 | Thermedical, Inc. | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US11871979B2 (en) | 2011-04-12 | 2024-01-16 | Thermedical, Inc. | Methods and devices for controlling ablation therapy |
US9138288B2 (en) | 2011-04-12 | 2015-09-22 | Thermedical, Inc. | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US10448987B2 (en) | 2011-04-12 | 2019-10-22 | Thermedical, Inc. | Methods and devices for controlling ablation therapy |
US11583330B2 (en) | 2011-04-12 | 2023-02-21 | Thermedical, Inc. | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy |
US11135000B2 (en) | 2011-04-12 | 2021-10-05 | Thermedical, Inc. | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US9445861B2 (en) | 2011-04-12 | 2016-09-20 | Thermedical, Inc. | Methods and devices for controlling ablation therapy |
US10307201B2 (en) | 2011-04-12 | 2019-06-04 | Thermedical, Inc. | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US8945121B2 (en) | 2011-04-12 | 2015-02-03 | Thermedical, Inc. | Methods and devices for use of degassed fluids with fluid enhanced ablation devices |
US9877768B2 (en) | 2011-04-12 | 2018-01-30 | Thermedical, Inc. | Methods and devices for heating fluid in fluid enhanced ablation therapy |
US9937000B2 (en) | 2011-04-12 | 2018-04-10 | Thermedical, Inc. | Methods and devices for controlling ablation therapy |
US8932284B2 (en) | 2012-02-07 | 2015-01-13 | Advanced Cardiac Therapeutics, Inc. | Methods of determining tissue temperatures in energy delivery procedures |
US8926605B2 (en) | 2012-02-07 | 2015-01-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature during tissue ablation |
US8961506B2 (en) | 2012-03-12 | 2015-02-24 | Advanced Cardiac Therapeutics, Inc. | Methods of automatically regulating operation of ablation members based on determined temperatures |
US9226791B2 (en) | 2012-03-12 | 2016-01-05 | Advanced Cardiac Therapeutics, Inc. | Systems for temperature-controlled ablation using radiometric feedback |
US8954161B2 (en) | 2012-06-01 | 2015-02-10 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for radiometrically measuring temperature and detecting tissue contact prior to and during tissue ablation |
US9014814B2 (en) | 2012-06-01 | 2015-04-21 | Advanced Cardiac Therapeutics, Inc. | Methods of determining tissue contact based on radiometric signals |
US10022176B2 (en) | 2012-08-15 | 2018-07-17 | Thermedical, Inc. | Low profile fluid enhanced ablation therapy devices and methods |
US9861336B2 (en) | 2012-09-07 | 2018-01-09 | Gynesonics, Inc. | Methods and systems for controlled deployment of needle structures in tissue |
US11583243B2 (en) | 2012-09-07 | 2023-02-21 | Gynesonics, Inc. | Methods and systems for controlled deployment of needle structures in tissue |
US10856838B2 (en) | 2012-09-07 | 2020-12-08 | Gynesonics, Inc. | Methods and systems for controlled deployment of needle structures in tissue |
US11890134B2 (en) | 2012-09-07 | 2024-02-06 | Gynesonics, Inc. | Methods and systems for controlled deployment of needle structures in tissue |
US10195467B2 (en) * | 2013-02-21 | 2019-02-05 | Boston Scientific Scimed, Inc. | Ablation catheter system with wireless radio frequency temperature sensor |
US20140236137A1 (en) * | 2013-02-21 | 2014-08-21 | Boston Scientific Scimed, Inc. | Ablation catheter system with wireless radio frequency temperature sensor |
US9033972B2 (en) | 2013-03-15 | 2015-05-19 | Thermedical, Inc. | Methods and devices for fluid enhanced microwave ablation therapy |
US9610396B2 (en) * | 2013-03-15 | 2017-04-04 | Thermedical, Inc. | Systems and methods for visualizing fluid enhanced ablation therapy |
US10058385B2 (en) | 2013-03-15 | 2018-08-28 | Thermedical, Inc. | Methods and devices for fluid enhanced microwave ablation therapy |
US10617805B2 (en) | 2014-03-20 | 2020-04-14 | Exploramed Nc7, Inc. | Fluid measuring reservoir for breast pumps |
US10383686B2 (en) | 2014-11-19 | 2019-08-20 | Epix Therapeutics, Inc. | Ablation systems with multiple temperature sensors |
US11534227B2 (en) | 2014-11-19 | 2022-12-27 | Epix Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
US9510905B2 (en) | 2014-11-19 | 2016-12-06 | Advanced Cardiac Therapeutics, Inc. | Systems and methods for high-resolution mapping of tissue |
US9517103B2 (en) | 2014-11-19 | 2016-12-13 | Advanced Cardiac Therapeutics, Inc. | Medical instruments with multiple temperature sensors |
US9522036B2 (en) | 2014-11-19 | 2016-12-20 | Advanced Cardiac Therapeutics, Inc. | Ablation devices, systems and methods of using a high-resolution electrode assembly |
US9522037B2 (en) | 2014-11-19 | 2016-12-20 | Advanced Cardiac Therapeutics, Inc. | Treatment adjustment based on temperatures from multiple temperature sensors |
US9592092B2 (en) | 2014-11-19 | 2017-03-14 | Advanced Cardiac Therapeutics, Inc. | Orientation determination based on temperature measurements |
US10660701B2 (en) | 2014-11-19 | 2020-05-26 | Epix Therapeutics, Inc. | Methods of removing heat from an electrode using thermal shunting |
US10499983B2 (en) | 2014-11-19 | 2019-12-10 | Epix Therapeutics, Inc. | Ablation systems and methods using heat shunt networks |
US10413212B2 (en) | 2014-11-19 | 2019-09-17 | Epix Therapeutics, Inc. | Methods and systems for enhanced mapping of tissue |
US11135009B2 (en) | 2014-11-19 | 2021-10-05 | Epix Therapeutics, Inc. | Electrode assembly with thermal shunt member |
US11701171B2 (en) | 2014-11-19 | 2023-07-18 | Epix Therapeutics, Inc. | Methods of removing heat from an electrode using thermal shunting |
US11642167B2 (en) | 2014-11-19 | 2023-05-09 | Epix Therapeutics, Inc. | Electrode assembly with thermal shunt member |
US10231779B2 (en) | 2014-11-19 | 2019-03-19 | Epix Therapeutics, Inc. | Ablation catheter with high-resolution electrode assembly |
US10166062B2 (en) | 2014-11-19 | 2019-01-01 | Epix Therapeutics, Inc. | High-resolution mapping of tissue with pacing |
US10675081B2 (en) | 2015-03-25 | 2020-06-09 | Epix Therapeutics, Inc. | Contact sensing systems and methods |
US11576714B2 (en) | 2015-03-25 | 2023-02-14 | Epix Therapeutics, Inc. | Contact sensing systems and methods |
US9636164B2 (en) | 2015-03-25 | 2017-05-02 | Advanced Cardiac Therapeutics, Inc. | Contact sensing systems and methods |
WO2016164853A1 (en) * | 2015-04-08 | 2016-10-13 | Naya Health, Inc. | Fluid measuring reservoir for breast pumps |
US11179197B2 (en) | 2016-03-15 | 2021-11-23 | Epix Therapeutics, Inc. | Methods of determining catheter orientation |
US9993178B2 (en) | 2016-03-15 | 2018-06-12 | Epix Therapeutics, Inc. | Methods of determining catheter orientation |
US11389230B2 (en) | 2016-03-15 | 2022-07-19 | Epix Therapeutics, Inc. | Systems for determining catheter orientation |
US11013555B2 (en) | 2016-08-11 | 2021-05-25 | Thermedical, Inc. | Devices and methods for delivering fluid to tissue during ablation therapy |
US9743984B1 (en) | 2016-08-11 | 2017-08-29 | Thermedical, Inc. | Devices and methods for delivering fluid to tissue during ablation therapy |
US10993770B2 (en) | 2016-11-11 | 2021-05-04 | Gynesonics, Inc. | Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data |
US11419682B2 (en) | 2016-11-11 | 2022-08-23 | Gynesonics, Inc. | Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data |
US11219483B2 (en) | 2016-11-14 | 2022-01-11 | Gynesonics Inc. | Methods and systems for real-time planning and monitoring of ablation needle deployment in tissue |
US11617618B2 (en) | 2017-04-27 | 2023-04-04 | Epix Therapeutics, Inc. | Contact assessment between an ablation catheter and tissue |
US10893903B2 (en) | 2017-04-27 | 2021-01-19 | Epix Therapeutics, Inc. | Medical instruments having contact assessment features |
US10888373B2 (en) | 2017-04-27 | 2021-01-12 | Epix Therapeutics, Inc. | Contact assessment between an ablation catheter and tissue |
US11612431B2 (en) | 2017-05-04 | 2023-03-28 | Gynesonics, Inc. | Methods for monitoring ablation progress with doppler ultrasound |
US11083871B2 (en) | 2018-05-03 | 2021-08-10 | Thermedical, Inc. | Selectively deployable catheter ablation devices |
US11918277B2 (en) * | 2018-07-16 | 2024-03-05 | Thermedical, Inc. | Inferred maximum temperature monitoring for irrigated ablation therapy |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11583330B2 (en) | Devices and methods for remote temperature monitoring in fluid enhanced ablation therapy | |
US11918277B2 (en) | Inferred maximum temperature monitoring for irrigated ablation therapy | |
US10022176B2 (en) | Low profile fluid enhanced ablation therapy devices and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THERMEDICAL, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CURLEY, MICHAEL G., MR.;REEL/FRAME:028271/0325 Effective date: 20120524 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |